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The cells of vascular tissues are subject to biophysical and biochemical cues from 
their microenvironment. These cues are relayed to cells via adhesion receptors on the cell 
surface to components of the extracellular matrix, cytoskeleton-linked proteins and stretch-
sensitive ion channels. These cues can influence cell alignment, morphology, proliferation 
and differentiation. A major challenge in engineering materials for vascular grafts is to 
understand and harness the mechanosensory mechanisms of cells to develop more effective 
therapies. Syndecan-1 is a transmembrane cell surface proteoglycan that has been shown 
to play a role in flow sensation in the glycocalyx of arteries, affecting endothelial cell 
proliferation and phenotype. Because of its interactions with cytoskeletal and focal 
adhesion associated proteins, it may serve as a mechanosensor for substrate-mediated cues. 
To date, the mechanisms of mechanical environment sensation through syndecan-1 are not 
well understood. This work tests the hypothesis that syndecan-1 is a key molecule in 
vascular cell mechanosensing and phenotype switching. We examine how cellular 
mechanosensing and adaptation to surfaces of various stiffness and nanotopography are 
 vii 
affected by syndecan-1. We determine what players of cytoskeletal rearrangement and 
nanotopography sensation are affected by syndecan-1 in this context. We also developed 
FRET-based syndecan-1 tension sensors to visualize syndecan-1 activation during 
mechanosensation and determine what domains of syndecan-1 are important to its 
mechanosensory function in vitro. Our findings demonstrate that syndecan-1 tension is 
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Chapter 1. Introduction 
1.1   MOTIVATION 
A major challenge in engineering biomaterials is to create substrates that are designed 
to produce desired behaviors and phenotypes in endogenous or delivered cells. Vascular 
bypass grafting, which is performed in approximately 600,000 patients per year in the US, 
is an important area for the application of engineered biomaterials. In situations where 
autogenous vascular substitutes are unsuitable, unavailable or risky for the patient, artificial 
grafts have been utilized, but the materials used for these grafts generally perform poorly 
for vascular grafts of diameters less than 6 mm. Such grafts are often at risk for thrombosis 
or differ too greatly in mechanical behavior compared to endogenous vessels.(Abbott, 
Megerman, Hasson, L'Italien, & Warnock, 1987; Greisler, 1990) When synthetic vascular 
grafts are implanted, endogenous endothelial cells interact with the biomaterials to colonize 
the vascular graft and re-endothelialize the blood-graft interface.(Dixit, Hern-Anderson, 
Ranieri, & Schmidt, 2001) The biophysical cues provided by the biomaterials profoundly 
alter the cells behavior and can lead endothelial cells to adopt a dysfunctional and 
inflammatory phenotype.(Wood et al., 2011)  
The cells of vascular tissues are subject to biophysical and biochemical cues that 
serve as powerful regulators of homeostasis and disease processes.(Hahn & Schwartz, 
2009; Lu & Kassab, 2011) These mechanical cues are sensed by many mechanisms 
including cell surface receptors, stretch sensitive ion channels and cytoskeleton-linked 
proteins.(Luo, Mohan, Iglesias, & Robinson, 2013) In therapeutic applications, a key 
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challenge is the development of engineered materials that can harness the curative effects 
of endogenous or delivered cells to enable the maximal therapeutic benefit from the 
implanted material. It is increasingly recognized that mechanical cues including substrate 
rigidity(Discher, Janmey, & Wang, 2005; Engler, Sen, Sweeney, & Discher, 2006; Swift 
et al., 2013) and the presence of nanotopological features(Dalby, Gadegaard, & Oreffo, 
2014; D. H. Kim, Provenzano, Smith, & Levchenko, 2012b) in the cell microenvironment 
can profoundly alter cell behavior and differentiation. The main motivation of this work is 
to contribute to the understanding of how vascular cells sense and respond to mechanical 
cues, including those presented by engineered materials. Our hope is that the findings of 
this research contribute to the scientific understanding of the mechanobiology of cell-
biomaterial interactions and provide some insights into how materials can be designed to 
use these effects to enhance therapies including synthetic vascular grafts.   
Previous work from our group demonstrated that syndecan-1 (SDC1) has a role in 
controlling endothelial phenotype in response to hemodynamic forces and vascular smooth 
muscle cell differentiation.(Voyvodic et al., 2014) (Chaterji, Lam, Ho, Proske, & Baker, 
2014) However, our knowledge of how SDC1 is involved in sensing these forces, what 
these forces are and how the absence of SDC1 affects the cell’s sensation of its environment 
is very limited. The first objective of this research was to examine the role of SDC1 in 
sensing substrate stiffness and nanotopography of engineered materials. The second 
objective was to develop a FRET-based SDC1 tension sensor that could be used to 
investigate the response of SDC1’s extracellular domain during cellular interactions with 
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substrates, utilizing the TSMod FRET tension sensing module.(Grashoff et al., 2010a) We 
developed a SDC1 tension sensor (SDC1-TS) and three mutant versions of the SDC1-TS 
to investigate the roles of the SDC1 ectodomain, glycosaminoglycan chains and 
cytoplasmic domain in SDC1 tension propagation. Our work demonstrated that tension on 
SDC1 decreases in response to decreased substrate compliance and that tension on SDC1 
is higher in regions of cellular adhesion. Additionally, we found that tension on SDC1 can 
be modulated by nanotopography and that the ectodomain plays an important role in this 
response. Finally, the third objective was to elucidate the mechanisms of SDC1 tension 
propagation. Our work indicates that the αV integrins influence SDC1 tension and that 
SDC1 is responsive to shear stress. 
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1.2   THESIS ORGANIZATION 
In Chapter 1, the motivation for this dissertation study was discussed. The 
background and previous work that informed this research is discussed in Chapter 2. 
Chapter 3 describes the role of SDC1 in mechanosensing substrate cues. Chapter 4 
describes the design and validation of a FRET-based SDC1 tension sensor, as well as an 
exploration of SDC1 tension in response to engineered substrates. The tension sensors 
developed in Chapter 4 are used to elucidate the mechanisms of SDC1 tension propagation 
and the response of SDC1 tension during shear stress, described in Chapter 5. Conclusions 
resulting from this research and an exploration of potential future work are discussed in 





Chapter 2. Background 
2.1   OVERVIEW OF CELLULAR MECHANOTRANSDUCTION  
Cells are constantly bombarded with biophysical cues. These cues are converted 
into biochemical signals that affect a number of processes, from development and cellular 
homeostasis to cardiovascular disease and cancer progression.(Hahn & Schwartz, 2009; 
Lu & Kassab, 2011; N. Wang, 2017)  Cues from the extracellular matrix (ECM), in 
particular, can influence cell alignment, morphology, proliferation and differentiation 
(Kim, Provenzano, Smith, & Levchenko, 2012). Much interest exists in the identification 
of the players in mechanotransduction. To date, cell surface receptors, stretch sensitive ion 
channels and proteins linked to the cytoskeleton have been identified, but for many of these 
putative mechanosensors, little is understood about the mechanisms through which they 
transmit mechanical signals into cells to affect signaling and gene expression.(Luo et al., 
2013)  
At the onset of integrin interactions with the ECM, integrins are activated and 
cluster, recruiting focal adhesion kinase (FAK). During integrin activation, conformational 
changes occur on integrins, whose identity and specificity come from the combination of 
various α and β subunits. Mechanical cues received by the integrins are then relayed to the 
cytoskeleton via proteins such as talin, vinculin and paxillin. From there, actin assembly is 
regulated.(Martino, Perestrelo, Vinarsky, Pagliari, & Forte, 2018) Adding to the 
complexity of focal adhesions are the transmembrane proteins, such as the syndecans, that 
associate with both integrins and the ECM on the extracellular side. 
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2.2   SYNDECAN-1  
Syndecans, from the Greek syndein “to bind together,” are single-pass 
transmembrane proteins known for their binding of growth factors, interactions with the 
cytoskeleton and direct binding of the extracellular matrix via covalently bonded 
proteoglycans.(Bernfield et al., 1992) The syndecans share a number of characteristics. 
They possess a short cytoplasmic domain, comprised of two conserved regions and one 
variable region. The highly conserved transmembrane domain is followed by an 
ectodomain, which varies in size and composition with syndecan type.(Woods, 2001) 
Attached to the core ectodomain are glycosaminoglycan (GAG) chains: heparan sulfate 
chains (found on syndecans 1, 2, 3 and 4) and chondroitin/dermatan sulfate (found on 
syndecans 1 and 3). The four syndecans are believed to be present in all 
tetrapods.(Chakravarti & Adams, 2006)  
 Syndecan-1 (SDC1) is found on endothelial cells,(Voyvodic et al., 2014) 
vSMCs(Chaterji, Lam, et al., 2014), epithelial cells(Hayashida, Johnston, Goldberger, & 
Park, 2006) and macrophages.(Angsana et al., 2015) It is one of the most numerous 
proteins that comprise the endothelial glycocalyx, along with Syndecan-4.(B. M. Fu & 
Tarbell, 2013) The GAG chains present on SDC1’s extracellular domain bind members of 
the ECM directly via the heparin-binding domains present on the ECM. SDC1possesses a 
docking site for integrins αVβ3 and αVβ5, which it can activate.(Mattson, Turcotte, & 
Zhang, 2017; Rapraeger, 2013) The consequences of such activation include cell spreading 
and migration.(Morgan, Humphries, & Bass, 2007)    
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 Syndecan-1 has been implicated in a number of normal processes, as well as disease 
processes. Interactions of its GAG chains with growth factors and extracellular adhesion 
proteins are known to be involved in development.(Jenkins, Horst, Lancaster, & Mythreye, 
2018) SDC1 has also been identified as having contradictory roles in cancer, suppressing 
and inducing apoptosis in cancer cells, and regulating other processes, including 
angiogenesis, metastasis and proliferation.(Khotskaya et al., 2009; Mythreye & Blobe, 
2009) Soluble SDC1 (sSDC1) can deliver growth factors to neighboring cells upon 
proteolytic cleavage of the ectodomain. This was observed in cultured myeloma cells, in 
which sSDC1 in the culture medium transported growth factors to the nucleus of stromal 
cells (Stewart, Ramani, & Sanderson, 2015)  
2.3   VASCULAR SMOOTH MUSCLE CELL MECHANOTRANSDUCTION 
Vascular smooth muscle cells (vSMCs) form aligned, helical layers within the 
medial layer of blood vessels. Normal vSMCs have high expression levels of contractile 
proteins, such as calponin and SM22α, and reduction of their expression is indicative of 
maladaptive vSMC dedifferentiation into a more migratory and proliferative state. vSMC 
contractility contributes to arterial contraction and relaxation. They are also influenced and 
remodeled by circumferential stretch, shear stress, transmural pressure and biophysical 
cues relayed from the extracellular matrix.(Ahmad, Osborne, & Bendeck, 2007; Haga, Li, 
& Chien, 2007; Wolinksy & Glagov, 1967; Ye, Nesmith, & Parker, 2014). Cumulatively, 
these cues activate signaling pathways that control the behavior of vSMCs, with cyclic 
stretch has the greatest impact. Loss of vSMC contractility has potentially catastrophic 
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consequences for the aorta, such as weakening of the aortic wall, followed by aortic 
dissection.(Huang et al., 2010; Lesauskaite et al., 2001) 
Integrins play a major role in the mechanotransduction of cyclic stretch in vSMCs, 
mediating activation of the JNK pathway.(Katsumi, Naoe, Matsushita, Kaibuchi, & 
Schwartz, 2005) Stretch has also been shown to affect the affinity of integrins. For 
example, integrin αVβ3 affinity for ECM binding in response to stretch.(Katsumi et al., 
2005) Substrate stiffness is known to increase the presence of F-actin bundles in the focal 
adhesions of vSMCs and substrate topography has been shown to influence vSMC 
alignment.(Chaterji, Kim, et al., 2014; Peyton & Putnam, 2005). 
2.4   ENDOTHELIAL SHEAR-MEDIATED MECHANOTRANSDUCTION 
In the vascular system, endothelial cells are found in the intimal layer, forming the 
endothelium, which interfaces directly with blood flow. The movement of blood through 
blood vessels produces fluid shear stress parallel to the intimal layer, which can be laminar 
or oscillatory in nature. While endothelial cells are subject to shear stress that is normal to 
their function, aberrant hemodynamic flow can contribute to disease states, such as 
atherosclerosis, which arise from the maladaptive response of endothelial cells. Regions of 
the vascular tree that tend to experience more oscillatory flow, such as the branch points of 
the aorta, are prone to developing atherosclerotic plaques, and in animal models of 
atherosclerosis, atherosclerotic plaque formation has been induced by the surgical 
perturbation of blood flow. These findings suggest that endothelial cells perceive shear 
stress via a mechanosensor or several. 
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 To date, the glycocalyx, of which SDC1 is a part, has been suggested as possessing 
a shear stress mechanosensation role, but other proteins have been implicated, as well. 
Platelet endothelial cell adhesion molecule-1 (PECAM-1), which is involved in the 
junctional interactions between endothelial cells, have been shown to respond to shear 
stress, mediating alignment, and Akt phosphorylation.(Tzima et al., 2005) PECAM-1 and 
ERK phosphorylation have been induced following direct force exertion onto PECAM-1 
via  magnetic bead experiments.(Osawa, Masuda, Kusano, & Fujiwara, 2002)  
Additionally, when endothelial cells expressing a PECAM-1 tension sensor were exposed 
to shear stress, tension was found to increase on PECAM-1 at the cell-cell junctions, while 
non-junctional PECAM-1 tension was unchanged.(Conway et al., 2013)  
VE-Cadherin has also been identified as a potential mechanosensor or at least an 
adaptor to a mechanosensor of shear stress. Loss of VE-Cadherin leads to the abolishment 
of integrin activation under shear stress and direct force application on VE-Cadherin via 
magnetic beads leads to changes in the actin cytoskeleton and increased cell 
stiffness.(Barry, Wang, & Leckband, 2015; Tzima et al., 2005)  A VE-Cadherin FRET 
tension sensor demonstrated that under static conditions, junctional VE-Cadherin tension 
is higher within cell-cell junctions than elsewhere on the cell and decreases in response to 
shear stress.(Conway et al., 2013) VEGFR3 has been suggested as a mechanosensor of 
shear stress magnitude. Endothelial cells vary in their sensitivity to shear stress, depending 
on their location in the vascular tree, and some evidence exists for VEGFR2 and VEGFR3 
in tuning this sensitivity.(Baeyens et al., 2015)  
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 What senses shear stress at the surface of an endothelial cell? As a component of 
the flow-interfacing glycocalyx, SDC1 is an appealing candidate. Our group found that 
knockout of SDC1 reduced the shear-stress-induced phosphorylation of Akt and spatial 
distribution of paxillin phosphorylation in endothelial cells. Knockout of SDC1 also 
reduced the shear-stress-induced activation of RhoA.(Voyvodic et al., 2014) A criticism of 
previous efforts to identify SDC1 as a mechanosensor is that the signaling pathways 
affected by loss of SDC1 are also downstream of integrin activation, necessitating the 
parsing of SDC1 and integrin roles.(Givens & Tzima, 2016) However, SDC1’s direct 
association with the cytoskeleton via its cytoplasmic domain suggests that forces exerted 
on SDC1 could be transmitted to the cytoskeleton. More than one shear stress 
mechanosensor may exist.  
2.5   MICRO- AND NANOPATTERNED SUBSTRATES 
In vivo, topography is presented to the cells via ECM proteins of the basement 
membrane and encompasses a range of sizes.(Gray & Stroka, 2017) Collagen fibrils, which 
possess diameters of 20-200 nm , can direct the migration and polarity of cells.(H. N. Kim 
et al., 2013) Collagen fibrils can also organize into collagen fibers, which are several 
microns in diameter. Thus, significant interest exists in tissue engineering to design nano- 
and microtopography that maintains or induces desired behaviors in cells. Engineered 
materials featuring micro- and nanotopography have been employed to manipulate cell 
adhesion, migration, differentiation, morphology, and a host of other characteristics, with 
the underlying aim of improving engineered tissues. A number of material variables can 
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be adjusted to achieve these influences: stiffness, chemistry, ECM coatings, feature size 
and others. Many geometries are possible, from pits and pillars to fibers, grooves to dots, 
to name a few.  
 In the medial layer of blood vessels, vascular smooth muscle cells are surrounded 
by elastin and collagen and elongated in a helical pattern. The elongation of smooth muscle 
cells is important not only for their contractility, but also the maintenance of the inner 
diameter of blood vessels and blood pressure.(H. N. Kim et al., 2013)  Nanogrooved 
poly(methyl methacrylate) and poly(dimethylsiloxane) substrates were shown to induce 
the alignment and elongation of smooth muscle cells while reducing their proliferation.(E. 
Yim et al., 2005) Work from our own group found that the combination of increased 
substrate stiffness and nanopatterning upregulated the expression of RhoA, Rock1 and 
Rock2. Nanopatterning in the absence of a substrate with optimal stiffness increased 
vascular smooth muscle cell contractility. In general, nanopatterning also downregulated 
the expression of inflammatory markers.(Chaterji, Kim, et al., 2014)  
 Nanopatterns have been shown to impart more physiologically-relevant mechanical 
properties to vascular cells. vSMCs were cultured on poly(N-isopropylacrylamide) 
nanogrooves to induce alignment and then detached as a sheet. They demonstrated a 
maximum tensile stress similar to that of blood vessels, while cells cultured on flat substrate 
markedly lower maximum tensile stress.(Zorlutuna, Elsheikh, & Hasirci, 2009) 
Nanogrooved collagen films aligned endothelial cells and also improved their adherence 
under 10-20 dynes/cm2 shear stress.(Zorlutuna et al., 2009) 
 12 
2.6   FRET TENSION SENSORS 
Forster Resonance Energy Transfer (FRET) has become an important tool for the 
study of mechanotransduction, enabling the creation of molecular-scale tension sensors. 
Here, single-molecular fluorescence force spectroscopy will be discussed. In general, 
intramolecular FRET tension sensors consist of a pair of fluorophores joined by a connector 
of characterized force sensitivity. The fluorophores overlap in excitation and emission 
spectra such that excitation of the donor fluorophore results in the resonant transfer of 
energy to the acceptor fluorophore. As a consequence, the acceptor fluorophore emits light 
upon excitation of the donor in a manner that scales with the distance between the two 
fluorophores.(Aoki, Kamioka, & Matsuda, 2013) In theory, a FRET tension sensor of the 
appropriate force sensitivity can be introduced into a protein of interest to measure the 
forces exerted on that protein. As the distance between the fluorophores increases, the 
efficiency of FRET decreases, implying tension on the sensor.  
The foundation of an intramolecular FRET tension sensor is the linker that joins 
the donor and acceptor fluorophores, as it is the force sensitivity of the linker that is used 
to measure force within the protein containing the module. Another characteristic that is 
relevant to the performance of FRET linkers is their resistance to hysteresis. Two FRET 
linkers that have been used in existing FRET tension sensors include stFRET (a coiled-coil 
spring) and TSMod (a random coil flagelliform) of TSMod. The random coil flagelliform 
of TSMod consists of 40 amino acids [(GPGGA)8] and is derived from spider silk protein. 
This linker was characterized using optical tweezer calibration to have 1-6 pN sensitivity. 
In some works, “TSMod” refers to any tension-sensing module. In this dissertation, 
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“TSMod” refers to the specific random coil flagelliform used by Grashoff and colleagues. 
TSMod was also used in the talin, E-Cadherin, PECAM-1, β-spectrin and mucin-1 tension 
sensors, as well as the SDC1 tension sensor developed in this work. (Borghi et al., 2012; 
Conway et al., 2013; Grashoff et al., 2010a; Kumar et al., 2016a, 2016b; Paszek et al., 
2014) 
Another consideration that is important to the design of a FRET tension sensing 
module is the selection of a pair of fluorophores. The donor emission and acceptor 
excitation spectra of the fluorophores must overlap strongly.(Day, Booker, & Periasamy, 
2008) The fluorophores should be photostable, possess sufficient brightness and have 
minimal direct effects on the health of the cells that express them. Additionally, the Förster 
radius (radius at which 50% FRET occurs) should be low. The need for those 
characteristics has led to the identification of cyan fluorescent protein (CFP) and yellow 
fluorescent protein (YFP), and their derivatives, as a highly suitable FRET pair in living 
cells.(Bajar, Wang, Zhang, Lin, & Chu, 2016) One example of an optimized derivative of 
CFP is teal fluorescent protein (mTFP1).(Ai, Henderson, Remington, & Campbell, 2006) 
mTFP1. Compared to ECFP, mTFP1 has a narrower emission profiler, reducing bleed-
through. Other desirable characteristics include its high quantum yield and decreased 
sensitivity to photobleaching, compared to ECFP.(Ai et al., 2006) Mutations in YFP 
leading to improved acid sensitivity and quenchability by chloride ions led to the 
development of Venus.(Nagai et al., 2002) A mutation in Venus conferred a reduction in 
the dimerization of Venus and resulted in Venus A206K.(Zacharias, Violin, Newton, & 
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Tsien, 2002) mTFP1 and Venus are the donor-acceptor FRET pair used in 
TSMod.(Grashoff et al., 2010a) 
Several tension sensors have been developed for use as molecular force transducers, 
including stFRET and sstFRET, which are coiled-coil springs and TSMod, a random coil 
flagelliform. TSMod is the sensor used in the vinculin, talin tension sensor, as well as the 
SDC1 tension sensor developed in this work. (Grashoff et al., 2010a; Kumar et al., 2016a, 
2016b) 
 A number of techniques can be used to measure FRET. In fluorescence lifetime 
imaging (FLIM), the lifetime of the donor fluorophore is measured. As the donor is 
quenched by the presence of the acceptor, its lifetime is affected; close proximity between 
the donor and acceptor results in a shortened donor lifetime.(Swift et al., 2013) This method 
is considered the most quantitative method. Sensitized emission, the method used in this 
work, is intensity-based. In this technique, the intensity of the acceptor’s emission under 
donor excitation is influenced by its proximity to the donor. This method requires 
evaluation of the direct excitation of the acceptor by the donor’s excitation using bleed-
through (acceptor-only and donor-only) controls.(Hachet-Haas et al., 2006) The main 
shortcoming of this method is the fact that it is intensity-based. Intensity-based imaging is 
subject to the influence of the concentration of fluorophores. However, it has been shown 
that FRET efficiencies obtained from sensitized emission are similar to those obtained 
using FLIM.(Krieg, Dunn, & Goodman, 2014) 
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2.7   SYNDECAN-1 KNOCK-OUT MICE 
Vascular smooth muscle cells were harvested from the aortae of wild-type and 
syndecan-1 knockout (S1KO) littermates from a C57BL/6J background. Early 
characterization of S1KO mice revealed that loss that SDC1 did not cause morphological 
defects, although impaired would healing was observed.(Alexander et al., 2000; Stepp et 
al., 2002) S1KO mice have been utilized by our group in the past for study of SDC1 in the 
context of vSMCs and endothelial cells, (Chaterji, Lam, et al., 2014; Voyvodic et al., 2014) 
as well as in the work discussed in Chapter 4 of this dissertation.(Le et al., 2018)  
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Chapter 3. Syndecan-1 in Mechanosensing of Nanotopological Cues in 
Engineered Materials1 
3.1   INTRODUCTION 
Cell therapies have great potential to improve the quality of life of countless 
patients with incurable diseases or severe injury. By their active nature, cell therapeutics 
can adapt and integrate into host tissues to perform functions not possible with drugs or 
protein therapeutics. A major component of enabling effective cell therapies is the use of 
scaffolds or delivery systems that support the function and phenotype of the cells once 
delivered.(Chan & Leong, 2008) In such engineered scaffolds, a key challenge is the 
development of engineered materials that can potentiate the curative effects of endogenous 
or delivered cells to enable the maximal therapeutic benefit from the implanted 
material.(Dang & Leong, 2007) Such instructive scaffolds or templates can recapitulate the 
cell-cell, cell-ECM, and cell-soluble factor signaling to orchestrate a therapeutic 
effect.(Lutolf & Hubbell, 2005) Only when facilitated by such an appropriate scaffold or 
carrier can cell-based therapies, such as those used in osteoarthritis(Diekman & Guilak, 
2013) or in cardiac or vascular repair,(Lin et al., 2012) truly transform the landscape of 
tissue engineering.(Hill, Boontheekul, & Mooney, 2006; Karp & Langer, 2007) While 
there is much information on the use of chemical and biochemical signals to enhance 
engineered biomaterial function, the effects of physical forces and the mechanisms of 
 
Le, V., Lee, J., Chaterji, S., Spencer, A., Liu, Y. L., Kim, P., Yeh, H.C., Kim, D.H., Baker, A. B. (2018). 
Syndecan-1 in mechanosensing of nanotopological cues in engineered materials. Biomaterials, 155, 13-24. 
Victoria Le performed the majority of the research and analysis and authored a proportion of the manuscript. 
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mechanosensing of nanomechanical cues remain poorly defined and have begun to emerge 
as critical parameters in nanomaterial design.  
In particular, vascular tissue engineering has made great strides towards recreating 
artificial blood vessels to treat a variety of cardiovascular conditions, ranging from 
myocardial infarction and ischemia to peripheral vascular disease and wound healing after 
vascular injury.(Hoenig, Campbell, Rolfe, & Campbell, 2005; Lesman, Gepstein, & 
Levenberg, 2010; Patterson et al., 2012; Shin'oka, Imai, & Ikada, 2001) In the bench to 
bedside translation of engineered blood vessels, the importance of vascular integrity and 
the ability of vascular smooth muscle cells (vSMCs) to impart long-term stability to the 
engineered vessels is a key factor.(Frontini et al., 2011; Murakami & Simons, 2009; 
Samuel et al., 2013) The vSMCs populate the medial layer of blood vessels and are present 
in multiple layers embedded in the basement membrane, which consists of fibrillar 
collagens and elastin.(Ahmad et al., 2007; Wolinksy & Glagov, 1967) The cells are 
organized in an aligned helical pattern around the blood vessel circumference with the 
successive vSMC layers demonstrating alternating pitch directions.(Isenberg & Wong, 
2006) Within this structure, organized extracellular matrix (ECM) molecules provide 
mechanical stability to the cells as well as biophysical and biochemical cues within the 
vascular “niche.”(Nikolova, Strilic, & Lammert, 2007) On a biophysical level, the 
underlying ECM in the blood vessel provides nanotopological cues with feature sizes from 
tens to several hundreds of nanometers.(G. Abrams, Schaus, Goodman, Nealey, & Murphy, 
2000; G. A. Abrams, Bentley, Nealey, & Murphy, 2002; Farhadian, Contard, Sabri, 
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Samuel, & Rappaport, 1996; Hedin, Roy, Tran, Lundmark, & Rahman, 2000; Kalluri, 
2003) The nanotopographical cues can regulate the function of many cells types.(Bettinger, 
Langer, & Borenstein, 2009; D. H. Kim, Provenzano, Smith, & Levchenko, 2012a) We 
and others have shown that vSMCs respond to nanotopographical cues that can regulate 
their alignment and phenotype.(Chaterji, Kim, et al., 2014; Hu, Yim, Reano, Leong, & 
Pang, 2005; Y. Wang et al., 2014; E. K. Yim et al., 2005; Zhou et al., 2015) While the 
effects of these physical cues are now widely accepted, the mechanisms of 
nanotopographically-stimulated regulation remain largely unknown. Previous studies have 
implicated Rac1 GTPase as a sensory mechanism and basis for directional alignment of 
cells on nanopatterned surfaces.(Xia et al., 2008) In addition, knockdown of focal adhesion 
kinase leads to increased cell alignment of corneal epithelial cells with nanopatterns and 
regulated gene expression of nesprin-1 and -2.(Dreier, Raghunathan, Russell, & Murphy, 
2012) In vSMCs, nanopatterning led to a significant increase in RhoA ROCK1 and 
ROCK2, implicating these pathways as potential mediators of mechanotransduction to 
nanopatterned surfaces.(Chaterji, Kim, et al., 2014) Further, several studies have also found 
regulation of integrins, Src, p130Cas and actin reorganization in response to nanopatterned 
substrates.(Arnold et al., 2004; Arnold et al., 2009; Dreier et al., 2013)  
In this work, we examined the role of syndecan-1 (SDC1) in mechanosensing of 
nanopatterned substrates and material rigidity by vSMCs. Syndecan-1 (SDC1) is a 
transmembrane cell surface proteoglycan that is found on endothelial cells,(Voyvodic et 
al., 2014) vSMCs(Chaterji, Lam, et al., 2014) and macrophages(Angsana et al., 2015) in 
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the vascular system, as well as on many other cell types. Our group has recently shown that 
SDC1 regulates the inflammatory state of endothelial cells in response to shear 
stress(Voyvodic et al., 2014) and several studies have implicated heparan sulfate 
proteoglycans as key molecules in mechanosensing.(Baeyens et al., 2014; B. M. Fu & 
Tarbell, 2013; Tarbell, Simon, & Curry, 2014) In this study, we created materials with 
nanoscale contact guidance cues using ultraviolet (UV)-assisted capillary force lithography 
(CFL), a versatile molding technology for imparting nanoscale architecture to tissue 
scaffolds over large surface areas.(Suh, Park, & Kim, 2009) We grew vSMCs with genetic 
knockout of SDC1 and wild type phenotype on nanopatterned materials to explore 
mechanosensing and activation of the cells by nanotopographical cues. Our analyses 
support that SDC1 is a key molecule in regulating the vSMC response to nanopatterned 
substrates and alters mechanosensitive signaling pathways including those involving 
Yap/Taz, Smad2/3 and cytoskeletal regulators Rock1, Rac-1 and integrin-linked kinase 
(ILK).  
3.2   MATERIALS AND METHODS 
3.2.1. Nanopatterned materials 
Nanopatterned substrates were fabricated from a polyurethane acrylate (PUA) 
precursor, as described previously.(D. H. Kim et al., 2009) Briefly, an adhesion promoter 
(Minuta Tech) was applied to the glass coverslips by spin coating at 2000 rpm for 20 
seconds and the coverslips were then baked at 65°C for 20 min. A PUA-based polymer of 
commercially characterized stiffness (6.7 MPa or 2.4 GPa) was then spin coated onto the 
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glass substrate and a PDMS mold with nanogrooves having an 800:800 nm groove:gap 
ratio with a 400 nm groove depth was placed on top of the PUA precursor layer. For 
nonpatterned surfaces, a mold with no features was placed on the polymer layer. Through 
capillary action, the polymer fills the mold and a nanopatterned surface is obtained.  The 
patterns were UV cured using a wavelength of 365 nm for 60 seconds. The substrates were 
then placed into well plates and plasma coated to facilitate protein adsorption. The 
substrates were then coated with a solution of 11% (w/v) type I collagen overnight to 
facilitate cell attachment.  
3.2.2. Cell isolation and culture 
Aortae were harvested from 6-10 week old male syndecan-1 knockout (S1KO) and 
wild type (WT) mice. Following harvest, the aortae were minced and a glass coverslip was 
placed over the tissue fragments. The cells were then cultured in MCDB-131 culture 
medium (Life Technologies) with 20% fetal bovine serum (FBS), L-glutamine and 
antibiotics. The vSMCs migrated out of the tissue and were allowed to proliferate. After 
the first passage, the cells were grown in MCDB-131 with 10% FBS, L-glutamine and 
antibiotics. The vSMCs were seeded onto the substrates at 50% confluence. For long-term 
drug treatment experiments, cells were seeded onto the substrates and treated 24 hours later 
with 1% DMSO, 10 µM Y-27632 (Sigma), or 10 µM Verteporfin (Tocris) in culture 
medium for 48 hours. For short-term drug treatment experiments, cells were seeded onto 
the substrates and treated 24 hours later with 0.1% DMSO, 10 µM Y-27632 (Sigma), 10 
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µM Verteporfin (Tocris), 1 µM Latrunculin A (Abcam) or 10 µM Nocodazole (Abcam) in 
culture medium for 2 hours. 
3.2.3. Immunostaining and image analysis 
Following the treatments, the cells were washed with PBS at 37°C and fixed with 
4% paraformaldehyde for 10 min. The cells were then washed three times with PBS and 
permeabilized with 0.2% Triton X-100 for 5 min. The cells were blocked with 1% BSA in 
PBS for 40 min and stained with primary antibody diluted in PBS with 1% BSA overnight. 
The primary antibodies and dilution used in the study are shown in Table 3.1. The cells 
were then rinsed PBS for 10 min three times. Secondary antibodies conjugated to 
fluorophores were added at 1:1000 dilution in 1% BSA in PBS containing 1 µg/ml of DAPI 
for nuclear staining. After 75 min of incubation at room temperature, the cell were rinsed 
extensively with repeated PBS washes. The cells were mounted and coverslipped in anti-
fade mounting media (Vector Laboratories, Inc.).  
Table 3.1. Antibodies used for immunostaining 
Antibody Target Dilution Vendor Catalog 
ILK 1:50 BD Biosciences 611803 
Paxillin 1:50 Santa Cruz H-114 
Phospho-MLC 1:50 VWR PA517726 
Phospho-Smad2 1:50 Thermo 44-244G 
Phospho-Smad2/3 1:50 Cell Signaling, Inc. 8828S 
Phospho-Smad3 1:100 Abcam ab52903 
Rac1 1:50 Life Technologies PA1-091 
Rock1 1:100 Life Technologies PA5-22262 
Smad2/3 1:50 BD Biosciences 610842 
Smad2/3 1:50 Santa Cruz Sc-133098 
Yap/Taz 1:50 Cell Signaling, Inc. 8418S 
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The cells were imaged using an epifluorescent microscope (Axio Observer 
microscope, Carl Zeiss, Inc.). For each coverslip, ten images were taken at randomly 
selected areas. The same imaging exposure time and illumination intensity was used for all 
groups that were compared to each other following analysis. The cells and nuclei were 
selected and analysis was performed using computer-assisted morphometry with 
Metamorph 7.0 (Molecular Devices, LLC) or ImageJ. Measurements were made of the 
elliptical form factor (EFF; defined as the major axis divided by minor axis) and shape 
factor (defined as 4π[Area]/[Perimeter]2). For the quantification of cell alignment, the 
perimeters of the cells were traced and the angle of the cells calculated from the major axis 
of the cell area and compared to the angle of the nanogrooves in the substrate. For 
measurements of cell intensity, mean immunofluorescence intensities were measured in 
the selected areas using ImageJ. Background intensity outside the cell areas was subtracted 
from the measurements of mean cytoplasmic and nuclear intensity.  
3.2.4. Flow cytometric analysis of cells  
Cells were seeded onto coverslips of engineered substrates at 30% confluency. For 
all of the procedure, the buffers were supplemented with 2 mM sodium orthovanadate and 
50 mM NaF to prevent alterations in the phosphorylation state of proteins. After 48 hours, 
the adherent vSMCs were washed with PBS and treated with Accutase (Millipore) for 5 
minutes at 25°C. A cell scraper was used to ensure cell detachment from the engineered 
substrates. Cells were centrifuged at 8°C for six minutes at 400g, and the supernatant was 
aspirated. The pellet was resuspended and incubated in fixation/permeabilization buffer 
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(BD Pharmigen) at 4°C for 50 minutes. Permeabilization/wash buffer (BD Pharmigen) was 
added to cells, and the cells were again centrifuged and the supernatant aspirated. For 
intracellular staining, cells were incubated with antibodies against Rock1, ILK, Smad2/3 
and p-Smad2/3 in permeabilization/wash buffer, as outlined in Table 3.2. The cells were 
next rinsed twice with permeabilization/fixation buffer, centrifuged and the supernatant 
was aspirated. The cells were resuspended in stain buffer (BD Pharmigen) and flow 
cytometry was performed using the LSRFortessa flow cytometer (BD). Flow cytometry 
data was analyzed using Flowjo software.   
Table 3.2. Antibodies used for flow cytometry 
Antibody Target Fluorochrome Vendor Catalog 
Rock1 Alexa 488 Abcam ab205432 
ILK PE Santa Cruz sc-20019PE 
Smad2/3 Alexa 647 BD PE-CF594 
p-Smad2/3 PE-CF594 Thermo 44-244G 
Rabbit IgG (Control) Alexa 488 Abcam ab199091 
Mouse IgG2b (Control) PE Santa Cruz sc-2868 
Mouse IgG2a (Control) Alexa 647 Santa Cruz sc-24637 
Mouse 1gG1κ (Control) PE-CF594 BD 562292 
 
3.2.5. Measurement of cell mechanics using micropipette aspiration  
Micro-capillary tubes were pulled using a micropipette puller and then the tip was 
cut and smoothed with a microforge. The micropipette was then filled with PBS using a 
MicroFil needle. Smooth muscle cells were trypsinized and resuspended in MCDB-131 
media. The cell suspension was pipetted between two coverglasses and positioned on the 
microscope. Cells were suctioned onto the micropipette with a small suction force, no 
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greater than 50 Pa, and moved away from the coverglass. Pressure was increased by 100 
Pa and images were captured at 10 second intervals for 100 seconds. This process was 
repeated four times for each cell while recording the precise pressure differences. 
3.2.6. Particle-tracking microrheology 
Cells were seeded on 35 mm tissue culture dishes and grown to ~80% confluence 
before ballistic injection of red fluorescent 100 nm carboxylated polystyrene particles 
(Thermo Scientific). The ballistic injection was conducted using a Biolistic® PDS-
1000/He particle delivery system (Bio-Rad) as previously described.(Wu et al., 2012) In 
brief, nanoparticles were dialyzed against ethanol and deposited onto microcarriers and 
allowed to dry for 40 min. Rupture disks of 900 psi were used for single-microcarrier 
adaptor. After ballistic injection, cells were gently washed twice with 1X PBS and fresh 
cell culture medium. These cells were incubated in an incubator for at least 4 h to allow 
cells to recover from ballistic injection. Particle-injected cells were then reseeded into a 
chambered coverglass to grow overnight before observation on a microscope. Staining with 
Hoechst 33258 (Thermo Fisher) and CellMask Deep Red (Thermo Fisher) was performed 
of the nuclear DNA and plasma membrane. Cells were then treated with 60 mM KCl in 
cell culture media for 10 min to induce contraction(Peng, Wang, Lu, & Ran, 2010) and 
fluorescent particle tracking was again performed. Following tracking of the contracted 
cells, the media containing KCl was aspirated, and the cells rinsed twice with PBS. The 
cells were then treated with 10 μM of the Rock inhibitor Y-27632 (Sigma) for 15 min to 
induce relaxation in the cells(X. Fu, Gong, Jia, Somlyo, & Somlyo, 1998) before the 
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initiation of testing.  All of the treatments and particle tracking were performed at 37ºC. 
Treatments remained present for the duration of testing. To probe the rheological properties 
within cells, we tracked ballistically injected particles and extracted the viscoelastic moduli 
using a frequency-dependent Stokes-Einstein equation.(Mason, Ganesan, van Zanten, 
Wirtz, & Kuo, 1997; Xu, Viasnoff, & Wirtz, 1998) A custom-built, two-photon 3D tracking 
microscope, termed TSUNAMI (Tracking of Single particles Using Nonlinear And 
Multiplexed Illumination), was used to track fluorescent particles for 60 s. The scheme of 
the TSUNAMI system has been previously reported and its use for tracking biomolecules 
in living cells has been demonstrated.(Perillo et al., 2015)  Here, we used a Ti:sapphire 
laser output at 20 mW and 825 nm for tracking experiments. TSUNAMI can achieve 
localization accuracy as good as 17 nm in xy and 35 nm in z-direction. The temporal 
resolution of these particle-tracking experiments is 5 ms.(Perillo et al., 2015)  
The detailed protocol for particle-tracking microrheology has been reported.(Wu et 
al., 2012) In brief, the trajectories were analyzed by custom software in MATLAB (The 
MathWorks, Natick, MA) to calculate the time-averaged mean squared displacement 
(MSD): 
MSD(𝜏) = 〈[𝑥(𝑡 + 𝜏) − 𝑥(𝑡)]2 + [𝑦(𝑡 + 𝜏) − 𝑦(𝑡)]2〉 
where τ is the time lag and t the is elapsed time. The local creep compliance of the 




) ∗ MSD(𝜏) 
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where kB is the Boltzmann constant, T is the absolute temperature, and a is the radius of 
the particle. The creep compliance is a measure of the deformability of the cytoplasm.  
The generalized Stokes-Einstein equation was then used to calculate the frequency-






MSD(𝜏)𝛤((1 + 𝛼(𝜏))(1 + 𝛽(𝜏))/2)
 
where ω = 1/τ, a is the radius of the particle, Γ is the gamma function, α(τ) and β(τ) are the 
first derivative and second derivative of the logarithm MSD-time lag curve, respectively. 
The G*(ω) curves were fitted with third-order polynomial in the logarithmic space, and 
then the first derivative, 𝛼𝐺(𝜔), and the second derivative, 𝛽𝐺(𝜔), were directly calculated 
from the fitted polynomial function. The following two equations were used to calculate 
























3.2.7. Statistical analysis 
All results are shown as mean ± standard error of the mean, unless otherwise 
specified. Comparisons between only two groups were performed using a two-tailed 
Student’s t-test with differences were considered significant at p<0.05. Multiple 
comparisons between groups were analyzed by two-way ANOVA followed by a Tukey 
post-hoc test. A two-tailed p-value of less than 0.05 was considered statistically significant. 
For nonparametric data, a Kruskal-Wallis test was used followed by the Conover-Iman test 
to compare between multiple groups. 
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3.3   RESULTS 
3.3.1.  Syndecan-1 knockout reduces cellular alignment with nanogrooves under TNF-
α treatment 
Cellular alignment to nanogrooves has been observed for many cell types and 
occurs on surfaces with nanoscale features beyond 35 nm in dimension.(Loesberg et al., 
2007) To examine the effect of SDC1 knockout on the ability of vSMCs to align to a 
nanopattern, we created PUA materials with nanogrooves (800 nm grooves) using UV 
assisted capillary force lithography and confirmed the nanopatterning using scanning 
electron microscopy (Figure 3.1). The nanopatterning was accurate on both the more 
compliant polymer with a Young’s modulus of 6.7 MPa (NOA76; Figure 3.1B) and the 
stiffer material with a modulus of 2.4 GPa (NOA86; Figure 3.1C). We isolated vSMCs 
from WT and S1KO mice and cultured them on the different surfaces for 48 hours. We 
performed a quantitative analysis of the alignment and morphology of the cells on 
nanopatterned and nonpatterned surfaces of both moduli. Under standard culture 
conditions, S1KO and WT vSMCs aligned similarly to the nanogrooves (Figure 3.2A, B). 
WT and S1KO vSMCs also elongated similarly to nanogrooves, as indicated by the 
elliptical form factor (EFF; Figure 3.2C). Treatment with TNF-α increased the elongation 
of the cells and caused them to align with the nanopatterning (Figure 3.3). Syndecan-1 
knockout vSMCs had reduced elongation in all of the substrates (Figure 3.3B, C). In 
addition, knockout of SDC1 reduced the alignment of the cells on both the 6.7 MPa and 
2.4 GPa modulus materials (Figure. 3.3D). To test the effect of Rock inhibition and 
Yap/Taz inhibition on alignment and elongation, we cultured the cells in the presence of 
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Y27632 and Verteporfin. Inhibition of Yap/Taz and Rock did not significantly affect 
orientation of the vSMCs in response to the nanogrooves (Figure 3.4A). In addition, 
Yap/Taz inhibition significantly reduced elongation for both genotypes (Figure 3.4C, D).  
3.3.2. Loss of syndecan-1 increases nuclear localization of Yap/Taz in response to 
nanopatterned substrates. 
 
The Hippo signaling pathway and its intermediates Yap and Taz have been linked 
to mechanosensing in many cell types.(Dupont et al., 2011) Immunostaining on vSMCs 
grown on the patterned and nonpatterned substrates demonstrated that S1KO vSMCs had 
increased nuclear localization of Yap/Taz on all of the substrates. In addition, on the 2.4 
GPa substrates nanopatterning led to increased nuclear localization of Yap/Taz (Figure 
3.5). Cytoplasmic Yap/Taz was similar between genotypes on equivalent substrates, both 
soft and stiff. Overall, the nuclear/cytoplasmic ratio of Yap/Taz increased in response to 
nanopatterning on 2.4 GPa substrates and this increase was significantly enhanced with 
SDC1 knockout. Treatment with Verteporfin (Hippo pathway inhibitor) or Latrunculin A 
(disruptor of actin cytoskeletal organization) eliminated differences in Yap/Taz 





3.3.3. Syndecan-1 knockout increases nuclear Smad2/3 in response to nanopatterning. 
TGF-β signaling pathway is known to be mechanically responsive(Baker et al., 
2008; Maeda et al., 2011) and nanotopography has been shown to alter Smad-mediated 
signaling in mesenchymal stem cells.(Kato et al., 2014) We grew WT and S1KO vSMCs 
on nanopatterned substrates and measured the phosphorylation and localization of 
Smad2/3, a mediator of vSMC function and downstream target of TGF-β signaling.(Ruiz-
Ortega, Rodriguez-Vita, Sanchez-Lopez, Carvajal, & Egido, 2007)  Knockout of SDC1 
increased the nuclear localization of Smad2/3 and led to an increase in total Smad2/3 in 
the cell (Figure 3.6A-B). Loss of SDC1 increased the nuclear localization of Smad2/3 on 
2.4 GPa substrates. Knockout of SDC1 also increased the cytoplasmic localization of 
Smad2/3 on 6.7 MPa nanopatterned substrates. S1KO vSMCs also had a significantly 
greater cytoplasmic Smad2/3 response to nanopatterning on 6.7 MPa substrates in 
comparison to WT. However, there was virtually no nuclear Smad2/3 response to 
nanopatterning on substrates of either stiffness. Phospho-Smad2/3 was significantly 
increased in the cytoplasm by loss of SDC1 for 2.4 GPa nonpatterned substrates. We 
treated the cells with inhibitors found that inhibition of Yap/Taz with Verteporfin reduced 
p-Smad2/3 in the nucleus in the S1KO cells grown on nanopatterned surfaces (2.4 GPa 
stiffness). Flow cytometric analysis showed increased Smad2/3 and p-Smad2/3 in S1KO 
vSMCs compared to WT in response to nanopatterning and on the 2.4 GPa substrate 
(Figure 3.9C). Yap/Taz inhibition significantly affected p-Smad2/3 nuclear localization. 
Smad2/3 localization was altered by disruption of actin polymerization (Figure 3.8B) 
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3.3.4. Syndecan-1 knockout alters distribution and levels of focal adhesion associated 
proteins. 
Integrin-linked kinase (ILK) is an integrin β1 adaptor protein that is essential for 
the formation of focal adhesions and has been implicated in cell matrix interactions(Sakai 
et al., 2003) as well as the regulation of vSMC function and response to injury.(Ho et al., 
2008) Rac1 is a Rho GTPase involved in the regulation of cytoskeletal 
rearrangement(Bustelo, Sauzeau, & Berenjeno, 2007) and is a key molecule in vSMC 
migration, proliferation and the formation of intimal hyperplasia.(Autieri, Kelemen, & 
Wendt, 2003; Yu et al., 2015; Zhu et al., 2010) In development, ILK regulates the 
formation of the vascular wall through a Rho/Rock1 mediated mechanism.(Kogata, Tribe, 
Fassler, Way, & Adams, 2009) For WT vSMCs grown on stiff substrates, there was an 
increase in ILK for cells grown on the nanopatterned substrates (Figure 3.7). In addition, 
there was a marked reduction in ILK for the S1KO cells on the stiffer substrates in 
comparison to WT cells. Elevated ILK levels in S1KO vSMCs compared to WT vSMCs 
in response to nanopatterning were also observed in analysis with flow cytometry (Figure 
3.9B). There was increased Rac1 in S1KO vSMCs that were grown on stiff, nanopatterned 
substrates (Figure 3.7). For both ILK and Rac1, there were no significant differences 
between the groups for cells grown on less stiff substrates. 
3.3.5. Syndecan-1 knockout increases Rho-associated protein kinase-1 (Rock1) and 
phospho-myosin light chain (p-MLC). 
Focal adhesions are important in mechanosensing of the ECM and applied physical 
forces. The activation of Rho signaling leads to contraction and an increase in cellular 
tension. To examine the effect of SDC1 knockout on the Rho signaling pathway, we 
examined Rock1 immunofluorescence intensity and localization. Rock1 activation leads to 
an increase in phosphorylation of myosin light chain. Loss of SDC1 increased Rock1 by 
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almost two-fold, particularly on stiff and nanopatterned substrates (Figure 3.10). On 6.7 
MPa substrates, Rock1 levels were very similar between genotypes. In response to 
nanopatterning, Rock1 was significantly increased in S1KO vSMCs compared to WT, 
approximately a 60% increase in S1KO compared to 12% in WT cells. In addition, myosin 
light chain (p-MLC) was in S1KO cells in comparison to WT cells on stiff substrates. 
Consistent with the immunostaining results, flow cytometric analysis also found increased 
Rock1 levels in S1KO vSMCs compared to WT cells in response to nanopatterning (Figure 
3.9A). 
3.3.6. Syndecan-1 knockout increases vascular smooth muscle cell stiffness and alters 
the response to contractile stimuli.   
As we observed a significant increase in Rock1, p-MLC and Rac-1 as well as 
increases in Yap/Taz and p-Smad2/3 in S1KO cells, we hypothesized that S1KO led to a 
cell state with greater cytoskeletal tension and stiffness. We grew the vSMCs on collagen-
coated alginate substrates that had varying compliance. After culturing the cells on the 
substrates, we released them from the plate with trypsin and measured their stiffness using 
micropipette aspiration. This analysis revealed a significant increase in the Young’s 
modulus of S1KO cells in comparison to WT cells on substrates of very soft (0.5 kPa) or 
relatively stiff (64 kPa) compliance (Figure 3.11). In addition, we further tested the 
mechanics of the cells using particle-tracking microrheology under control conditions, a 
contraction stimulus with KCl and treatment with a Rock inhibitor (Y27632). In WT 
vSMCs, we found that the elastic modulus increased under contraction and decreased after 
subsequent Rock inhibitor treatment (Figure 3.12C, D). Under baseline conditions, S1KO 
 33 
cells had increased elastic modulus consistent with increased contractile state. In addition, 
the modulus of the S1KO cells decreased in response to both KCl and Y27632 treatment. 
In WT cells, the viscous modulus increased with KCl treatment and decreased with Rock 
inhibition but this was not observed in the S1KO cells (Figure 3.12C, D).   
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3.4   DISCUSSION 
Nanotopographical features on engineered materials provide a means for 
controlling cell function and can provide a powerful means to create in vitro tissue 
equivalent culture systems or improve the response to implanted materials. Nanotopology 
is known to regulate the function of many cells types including stem cells,(Ahn et al., 2014; 
Carson et al., 2016) cardiomyocytes(D. H. Kim, Kshitiz, et al., 2012; Mengsteab et al., 
2016) and endothelial cells.(Liliensiek et al., 2010) The effects of nanotopographical 
features on vSMCs have been used to preferentially align cells in the creation of vascular 
conduits.(Barreto-Ortiz et al., 2013; Zorlutuna et al., 2009) While there is strong evidence 
for the concept that nanotopographical feature can strongly regulate cell function, the 
mechanisms of how cells sense and respond to these feature remains largely unexplained. 
In this work, we demonstrate that loss of the cell surface proteoglycan SDC1 can alter the 
response of vSMCs to nanotopography, leading to alterations in cell alignment in an 
inflammatory context, altering mechanosensing through Yap/Taz and Rho-mediated 
signaling and altering vSMC cell mechanics.  
Our group has shown that nanotopography can increase expression of markers of 
mature vSMC phenotype including calponin, αSMA and desmin.(Chaterji, Kim, et al., 
2014) In addition, nanogrooves similar to those used in this study, increased Rock1 and 
RhoA in comparison to nonpatterned surfaces.(Chaterji, Kim, et al., 2014) In this study, 
nanopatterning induced a large increase in nuclear localization of Yap/Taz on stiff 
substrates. The Hippo pathway is well known to be mechanoresponsive to underlying cues 
from the substrate such as matrix stiffness and attachment area.(Dupont et al., 2011) 
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Similarly, there was an increase in nuclear p-Smad2/3 in the vSMCs with nanopatterning 
on stiff materials. Yap/Taz binds to Smad transcription factors to regulate their 
function.(Varelas et al., 2010) Thus, the presence of nanogrooves provides increased 
activation of these pathways, effectively causing cell to sense the material as if it had 
increased stiffness or larger contact area.(Dupont et al., 2011) As our previous work has 
shown that nanopatterning increases many of the proteins involved in vSMC contraction 
(eg. calponin and αSMA)(Chaterji, Kim, et al., 2014) and Rac1 in this study, this supports 
an increase in contractile forces in the cell and increased cytoskeletal tension. Cytoskeletal 
tension is key in regulating the nuclear localization of Yap/Taz(Dupont et al., 2011) and 
thus provides a potential mechanism for the alterations in Yap/Taz localization observed 
with nanopatterning. In our study, changes in Yap/Taz localization were blocked by 
disruption of the actin cytoskeleton, further supporting cytoskeletal tension as a potential 
mechanism. 
Knockout of SDC1 caused a number of profound changes in the response of vSMC 
to nanopatterned surfaces. Our group has shown in prior studies that loss of SDC1 in 
vSMCs leads to increased proliferation, loss of mature vSMC markers including calponin 
and αSMA, and an increase in phosphorylation and amount of focal adhesion related-
molecules paxillin and Src.(Chaterji, Lam, et al., 2014) In this study, one of the most 
striking findings was the large increase in Rock1 with SDC1 knockout. Coupled with our 
findings here of increased Rac1 with SDC1 knockout, we suspected that loss of SDC1 led 
to an increased contractile state of the cell, even in spite of the loss of αSMA and calponin 
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observed in our previous study.(Chaterji, Lam, et al., 2014) We tested whether the SDC1 
knockout vSMCs had increased tension and/or stiffness in their cytoskeleton by measuring 
the mechanics of the cells in both a detached state with micropipette aspiration and using 
particle-tracking microrheology in an attached state. In the detached state without the 
tension of the cytoskeleton from attachment, the SDC1 vSMCs were about two-fold stiffer 
on stiff or very soft substrates, implying that these SDC1 knockout cells had an inherently 
greater stiffness. When attached, the SDC1 knockout cells were over four-fold stiffer, 
implying that the cells became even stiffer than WT cells after attachment and cytoskeletal 
engagement. With KCl treatment to induce contraction, the WT cells became stiffer and 
more viscous but, paradoxically, the SDC1 cells became less stiff and had roughly similar 
viscosity. A Rock inhibitor reduced the cell stiffness in both the WT and S1KO cells to 
similar levels, demonstrating that Rock1 elevation leads to increase in contraction in S1KO 
cells. While Rock inhibition altered the biomechanics of the cells it did not alter the 
signaling responses for Yap/Taz and p-Smad2/3. This suggests that the elevation in Rock1 
observed in the study are downstream to signaling through these pathways. Our study also 
suggests that this contraction causes increases in focal adhesion proteins and is consistent 
with an increase in nuclear Yap/Taz and p-Smad2/3, observed in our immunostaining 
experiments. Studies in other cell types have also linked SDC1 to focal adhesion assembly 
and cytoskeletal remodeling. In lung cancer cells, SDC1 was found to regulate focal 
adhesion disassembly by activating Rap1.(Ibrahim et al., 2012) In addition, SDC1 has been 
found to regulate integrin αVβ3 and αVβ5,(Beauvais, Burbach, & Rapraeger, 2004; 
Beauvais, Ell, McWhorter, & Rapraeger, 2009; McQuade, Beauvais, Burbach, & 
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Rapraeger, 2006) as well as several other integrins including α2β1(Vuoriluoto et al., 2008) 
and β4 integrin.(Ogawa, Tsubota, Hashimoto, Kariya, & Miyazaki, 2007) Moreover, in 
tumor cells, SDC1 knockdown reduced adhesion induced RhoA activation and activate 
Rac1.(Ishikawa & Kramer, 2010) Our results are consistent with these findings that imply 
increased adhesion with SDC1 loss and support that Rock1 may mediate increased 
cytoskeletal tension in the context of greater adhesion strength. 
Taken together, our studies have shown that nanotopography can alter signaling 
through the TGF-β and Hippo pathways through regulating the generation of cytoskeletal 
tension with the cells. In addition, SDC1 knockout creates a contractile state within the 
vSMCs leading to increased cell stiffness, changes in the response to contractile stimuli 
and regulating signaling through Yap/Taz and Smad2/3. Thus, nanotopology and SDC1 
knockout appear to have synergistic effects on the activation of the Yap/Taz and Rock-1 
mediated pathways. These findings add to our understanding of the mechanisms of 
mechanosensing in vSMCs and provide guidance for the creation of novel biomaterials that 




Figure 3.1. Fabrication of anisotropically nanofabricated substrates. (A) Diagram of 
UV-assisted capillary force lithography (CFL) used to fabricate substrates with 
nanogrooves. A mold coated with PDMS was placed on top of a coverslip with a 
polyurethane acrylate (PUA) layer. Capillary force drives the imprinting of the 
nanopatterned into the polymer layer, which is then polymerized with UV light. (B) 
Scanning electron microscopy (SEM) images of the surface with nanogrooves on a 
substrate with 6.7 MPa Young’s modulus. (C) SEM images of nanopatterned substrates a 




Figure 3.2. Alignment of vascular smooth muscle cells cultured on nanopatterned 
substrates under standard culture conditions. Wild type (WT) and syndecan-1 knockout 
(S1KO) vascular smooth muscle cells were grown on the engineered substrates for 48 
hours. (A) Quantification of the alignment of the cells with the patterned nanogrooves. (B) 
Shape factor for cells grown on flat and nanopatterned substrates. (C) Elliptical Form 
Factor (EFF), a measure of cell elongation, for the cells grown on the various substrates. 
(D) Change in the EFF (ΔEFF) comparing between cells grown on the patterned and 
nonpatterned surfaces. *p<0.05 versus WT group on the same substrate. †p<0.05 versus 
WT cells grown on a nonpatterned substrate. ‡p<0.05 versus S1KO cells grown on a 




Figure 3.3. Syndecan-1 knockout reduces vascular smooth muscle cell (vSMC) 
alignment to nanogrooves under TNF-α treatment. (A) Representative phase contrast 
images of wild type (WT) and syndecan-1 knockout (S1KO) vSMC morphology and 
orientation on patterned and nonpatterned surfaces. Cells were grown on the substrata for 
48 hours under treatment with 20 ng/ml TNF-. Bar = 25 m. (B) Elliptical form factor 
(EFF), a measure of cell elongation, for the cells grown on the various substrates. (C) 
Change in the EFF (ΔEFF) comparing between cells grown on the patterned and 
nonpatterned surfaces. (D) Alignment of the cells with the patterned nanogroove. The angle 
given is the angle between the grooves and the major axis of the cell (lower angle is more 
aligned). *p<0.05 versus WT group on the same substrate. †p<0.05 versus WT cells grown 
on a nonpatterned substrate. ‡p<0.05 S1KO cells grown on a nonpatterned substrate. 
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Figure 3.4. Alignment of vascular smooth muscle cells cultured on nanopatterned 
substrates in response to drug treatment.  Wild type (WT) and syndecan-1 knockout 
(S1KO) vascular smooth muscle cells were grown on 2.4 GPa nanopatterned substrates for 
12 hours and treated with 1% DMSO, 10 µM Y27632 or 10 µM Verteporfin (VP) for 48 
hours. (A) Alignment of the cells with the patterned nanogrooves. †p<0.05 versus DMSO-
treated WT cells. (B) Shape factor (C) Elliptical Form Factor (EFF), a measure of cell 
elongation, for the cells grown on the various substrates. (D) Change in the EFF (ΔEFF) 
comparing between cells grown on the patterned and nonpatterned surfaces. *p<0.05 versus 
WT group of the same treatment and on the same substrate. †p<0.05 versus DMSO-treated 
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Figure 3.5. Yap/Taz nuclear localization is altered by nanopatterning and knockout 
of syndecan-1. Wild type (WT) and syndecan-1 knockout (S1KO) vascular smooth muscle 
cells (vSMCs) were grown on engineered substrates for 48 hours and then immunostained. 
(A) Images of immunostaining for Yap/Taz Bar = 200 µm. (B) Quantification of nuclear 
localization of Yap/Taz in response to the materials. *p<0.05 versus WT group on the same 
substrate. †p<0.05 versus same genotype grown on a nonpatterned substrate. ‡p<0.05 
between cells with a different genotype grown on a different substrate. (C) WT and S1KO 
vSMCs were grown 2.4 GPa nanopatterned substrates for 24 hours, treated with media 
only, 0.1% DMSO, 10 µM Y27632, 10 µM Verteporfin (Vert), 1 µM Latrunculin A (Lat 
A) or 10 µM Nocodazole (Noc) for 2 hours and immunostained. Images of immunostaining 
for Yap/Taz. Bar = 200 µm. (D) Quantification of nuclear localization of Yap/Taz in 
response to the materials and treatments. *p<0.05 versus WT group of same treatment. 





































































































































Smad2/3 pSmad2/3 Merge 
2.4 GPa A 













Figure 3.6. Syndecan-1 knockout and nanopatterning increase nuclear Smad2/3 
signaling. Wild type (WT) and syndecan-1 knockout (S1KO) vascular smooth muscle cells 
(vSMCs) were grown on engineered substrates for 48 hours and then immunostained for 
phospho-Smad2/3 (Ser465/467; p-Smad2/3) and Smad2/3. (A) Representative images of 
the immunostaining for Smad2/3 in WT and S1KO. Bar = 200 µm. (B) Quantification of 
nuclear localization of p-Smad2/3 and Smad2/3 in the vSMCs grown on engineered 
substrates. *p<0.05 versus WT group on the same substrate. †p<0.05 versus WT cells grown 




Figure 3.7. Syndecan-1 knockout and increased substrate stiffness decrease ILK 
signaling. Wild type (WT) and syndecan-1 knockout (S1KO) vascular smooth muscle cells 
(vSMCs) were grown on engineered substrates for 48 hours and then immunostained for 
ILK and Rac1. (A) Representative images of the immunostaining for ILK and Rac1. Bar = 
200 µm. (B) Quantification of cellular localization of Rac1 and ILK for 6.7 MPa and 2.4 
GPa substrates. Mean nuclear intensity, mean cytoplasmic intensity and ratio of mean 
nuclear intensity to mean cytoplasmic intensity. *p<0.05 versus WT group on the same 
substrate. †p<0.05 versus WT cells grown on a nonpatterned substrate. ‡p<0.05 versus 
S1KO cells grown on a nonpatterned substrate. 
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Figure 3.8. p-Smad2/3 localization to the nucleus is altered by Yap/Taz inhibition. WT 
and S1KO vSMCs were grown 2.4 GPa nanopatterned substrates for 24 hours, treated with 
media only, 0.1% DMSO, 10 µM Y27632, 10 µM Verteporfin (Vert), 1 µM Latrunculin A 
(Lat A) or 10 µM Nocodazole (Noc) for 2 hours and immunostained for Smad2/3 and 
phospho-Smad3 (Ser423/425; pSmad3). (A) Images of immunostaining for Smad2/3 and 
pSmad3. Bar = 200 µm. (D) Quantification of nuclear localization of Smad2/3 and pSmad3 
in response to the materials and treatments. *p<0.05 versus WT group of same treatment. 




Figure 3.9. Loss of Syndecan-1 increases Rock1, ILK, Smad2/3 and p-Smad2/3 
protein levels. Wild type (WT) and syndecan-1 knockout (S1KO) vascular smooth muscle 
cells (vSMCs) were grown on engineered substrates for 48 hours, stained with 
fluorochrome-conjugated antibodies. Median intensity of staining for (A) Rock1, (B) ILK, 
(C) Smad2/3 and (D) p-Smad2/3. *p<0.05 versus WT group grown on nonpatterned 6.7 
MPa substrate. †p<0.05 versus WT group grown on nonpatterned 2.4 GPa substrate. 
‡p<0.05 versus WT group grown on nanopatterned 6.7 MPa substrate. §p<0.05 versus 
S1KO group grown on nanopatterned 2.4 GPa substrate. ¶p<0.05 versus WT group grown 






Figure 3.10. Loss of Syndecan-1 increases Rock 1 and p-MLC signaling on 
nanopatterned substrates and substrata of increased stiffness. Wild type (WT) and 
syndecan-1 knockout (S1KO) vascular smooth muscle cells (vSMCs) were grown on 
engineered substrates for 48 hours and then immunostained. (A) Representative images of 
the immunostaining for Rock1 and p-MLC. Bar = 200 µm. (B) Quantification of nuclear 
and cytoplasmic Rock1 localization. (C) Representative images of the immunostaining for 
p-MLC.  Bar = 200 µm. (D) Quantification of p-MLC localization. *p<0.05 versus WT 
group on the same substrate. †p<0.05 versus WT cells grown on a nonpatterned substrate. 




Figure 3.11. Knockout of syndecan-1 increases the stiffness of vascular smooth muscle 
cells measured by micropipette aspiration. (A) Micropipette aspiration of cells tested at 
a suction pressure of 400 Pa. Bar = 10 µm. (B) Young’s Moduli of vascular smooth muscle 
cells grown on 0.5, 16 and 64 kPa substrates prior to testing. *p<0.05 versus WT cells on 






Figure 3.12. Syndecan-1 knockout vascular smooth muscle cells have increased 
stiffness under baseline conditions and have altered response to contractile stimuli. 
(A) Live cell imaging of WT and S1KO vSMCs with fluorescent nanoparticles. Bar = 10 
µm. (B) Representative 3D trajectories of ballistically injected fluorescent nanoparticles in 
WT and S1KO vSMCs with stimulation by KCl, followed by Rock inhibition. (C) Particle-
tracking microrheology analysis in cytoplasm for WT and S1KO vSMCs. The averaged 
mean-squared displacement (MSD) curves were calculated from trajectories and the 
averaged frequency-dependent elastic modulus (G’) and viscous modulus (G”) of the 
cytoplasm can be approximately computed from the MSD curves. The time step of the 3D 
particle tracking was 5 ms, and the prescribed tracking duration was set as 60 s. (D) 
Averaged elastic and viscous moduli for WT and S1KO vSMCs that were sequentially 
treated with a contractile stimulus (KCl) and then a Rock inhibitor (Y27632). All moduli 
were evaluated at a frequency of 1 Hz. *p<0.05 versus WT group on the same substrate. 
†p<0.05 versus WT cells grown on a nonpatterned substrate. ‡p<0.05 versus S1KO cells 





Chapter 4. Development of a Syndecan-1 FRET Tension Sensor 
4.1   INTRODUCTION 
 While several putative shear-stress mechanosensors have been identified, much is 
still unknown about shear stress mechanotransduction, especially at the surface of the cell. 
As a component of the flow-interfacing glycocalyx, SDC1 is an appealing candidate flow 
sensor. In previous work, our group found that knockout of SDC-1 reduced the shear-
stress-induced phosphorylation of Akt and spatial distribution of paxillin phosphorylation 
in endothelial cells. Knockout of SDC-1 also reduced the shear-stress-induced activation 
of RhoA.(Voyvodic et al., 2014) Our recent work found that loss of SDC1 resulted 
increased cellular stiffness, reduced alignment in response to nanogrooves and alterations 
in signaling pathways affected by substrate stiffness.(Le et al., 2018) These findings 
indicate a mechanosensory role for SDC1.  
Much has been hypothesized about the interactions of the external mechanical 
environment of cells with the glycocalyx, but very little is known about the transfer of 
forces to the glycocalyx components such as SDC1. Less still is known about what 
subdomains of SDC1 are involved in the propagation of tension across the protein. To 
probe how tension forms on SDC1, we created a syndecan-1 tension sensor (SDC1-TS) 
containing the TSMod tension sensing module in the ectodomain of SDC1, after amino 
acid 22 (Figure 4.1A-B, D). Flanking the TSMod (a 44-amino acid flagelliform elastic 
linker) are mTFP (donor) and Venus A206K (acceptor).(Grashoff et al., 2010a) 
Additionally, we generated three variants of the SDC1-TS to investigate the importance of 
SDC1’s ectodomain (TSΔEcto), GAG chains (TSΔGAG) and cytoplasmic domain 
(TSΔCyto) in tension propagation (Figure 4.1B, D), as well as donor- and acceptor-only 
controls (Figure 4.1C). We then applied the SDC1-TS and its variants to engineered 
 54 
substrates examine how tension on SDC1 is modulated by substrate stiffness and 
nanotopography. 
Collectively, these tension sensors enabled us to elucidate a number of previously 
unknown features of SDC1. We found that the GAG chains, which bind the ectodomain 
directly, contribute to SDC1 tension at the substrate-level (cell-substrate interface). At the 
surface level of the cell, the core ectodomain contributes to SDC1 tension. The cytoplasmic 
domain of SDC1 participates in off-loading tension via SDC1’s direct association with the 
cytoskeleton. In response to substrate compliance, SDC1 tension increases with increasing 
substrate stiffness. Finally, SDC1 tension is altered by the presence of nanogrooves.  
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4.2   MATERIALS AND METHODS 
4.2.1.  Creation of the SDC1-TS expression construct 
The recombinant lentiviral plasmid containing human SDC1 was purchased from 
Genecopoeia (cat# EX-A0087-Lv105). The tension sensing module was cloned from a 
vector Addgene (cat# 26021) (Grashoff et al., 2010b). The ORF of the tension sensing 
module (bases 947 to 2494) was cloned into the SDC1 vector after base 965 (5’ACG GCT 
GTA 3’) (Appendix B) by Geneocopoeia’s cloning service.  
4.2.2. Generation of the SDC1 tension sensor mutants 
The TSΔEcto vector was created via PCR using the primers indicated in Table 4.1 
from the SDC1-TS vector template. These primers were used to introduce NheI sites for 
the ligation of the PCR product. The resulting vector excludes bases 363 through 949 
(amino acids 22 through 217) of the human Sdc1 gene, leaving only 11 amino acids at the 
N-terminus of the ectodomain of SDC1. The TSΔGAG vector was created via site-directed 
mutagenesis of serines 37, 45, 47, 206 and 216 of the human SDC1 gene to alanine 
(Langford, Stanley, Cao, & Sanderson, 1998). The TSΔCyto vector was created via site-
directed mutagenesis of amino acid 278 (ATG, methionine) of the human SDC1 gene to a 
stop codon (TGA), removing amino acids 279 through 310, similar to a previous approach. 
(Miettinen, Edwards, & Jalkanen, 1994). Both site-directed mutagenesis services were 
performed by Genscript. The Sdc1M (donor-only) and Sdc1V (acceptor-only) constructs 
were created via PCR from the SDC1-TS vector template (Table 4.1).   
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Table 4.1. Primers used to generate ectodomain mutant of SDC1 tension 

























4.2.3. Molecular biology techniques 
PCR was performed with 10 ng of the construct vector, 33 ul of nuclease-free water, 
10 μl of 5x Fusion GC Buffer (New England Biolabs), 1 ul of 10 mM dNTPs (New England 
Biolabs), 2.5 ul of 10 μM forward primer and 2.5 ul of 10 μM reverse primer. Following 
PCR, the reactions were digested with 1 μl of 20,000 units/ml DpnI (New England Biolabs) 
at 37°C for 30 min. The reactions were PCR purified (Qiagen) and eluted into 30 μl of 
nuclease-free water. The PCR product was digested with 1 μl of 20,000 units/ml NheI (New 
England Biolabs) at 37C for 30 min.  Gel electrophoresis was performed at 75V using an 
8% agarose gel. Bands of the desired molecular weight were cut from the gels using a razor 
and gel extraction (Qiagen) was performed. 14 μl of the product was used for the ligation 
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reaction with 2 μl of T4 ligase and 3 μl of nuclease-free water. T4 ligase (New England 
Biolabs) in the ligation reactions were deactivated by water bath incubation at 65°C for 10 
min. 5 μl of the ligation product was transformed into Stbl3 E. coli competent cell line 
(Invitrogen, cat #C7373-03). 250ul of the culture was plated onto an LB agar plate 
containing 100 μg/ml ampicillin. The following day, isolated colonies were picked and 
cultured in LB broth for 16 hours.  
4.2.4. Cell culture 
Human umbilical vein endothelial cells (HUVECs) from a single donor (Lonza, 
#C-11200) were cultured in MCDB-131 culture medium (Gibco) with 7.5% fetal bovine 
serum (FBS), endothelial cell growth supplement (R&D Systems), L-glutamine and 
antibiotics. 293Ta cells (LT008; Genecopoeia, Inc.) were cultured in DMEM culture 
medium (Gibco) supplemented with 10% FBS, L-glutamine and antibiotics. 293Ta 
packaging cells (ATCC) were cultured in DMEM culture medium (Gibco) supplemented 
with 10% heat-inactivated FBS, L-glutamine and antibiotics. All cells were incubated at 
37°C with 5% CO2. Unless otherwise noted, cells were seeded onto glass-bottom dishes 
(MatTek). The glass-bottom dishes were coated with a solution of 11% (w/v) type I rat tail 
collagen (Corning) overnight at 4°C. 
4.2.5. Lentiviral transduction 
A lentiviral packaging kit (LT001; Genecopoeia, Inc.) was used to produce 
lentivirus. Packaging plasmids for the SDC1-TS, TSΔEcto, TSΔGAG or TSΔCyto sensors 
and donor-only or acceptor-only were co-transfected with the manufacturer’s lentiviral 
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expression clone into HEK 293Ta packaging cells. Prior to viral infection, HUVECs were 
cultured in MCDB-131 culture medium 5% heat-inactivated FBS, L-glutamine and 
antibiotics. Pseudovirus containing the lentiviral expression constructs was harvested and 
transduced into HUVECs in complete HUVEC culture medium containing 8 μg/ml 
polybrene. One day after transduction, the media was changed to complete HUVEC culture 
medium with 2 μg/ml puromycin. Fresh media with puromycin was added daily for five 
days to create the stable cell line.  
4.2.6. Immunostaining and confocal microscopy 
Endothelial cells expressing SDC1-TS, TSΔEcto, TSΔGAG, TSΔCyto, mTFP 
only, Venus only and non-transduced HUVECs at passage 8 were trypsinized and seeded 
at 5,000 cells/cm2 onto collagen-coated glass coverslips of 25 mm in diameter. Cells were 
cultured for 48 hours and washed with PBS at 37°C and fixed with 4% paraformaldehyde 
for 10 min. Cells were then washed three times with PBS and permeabilized with 0.2% 
Triton X-100 for 5 min. The cells were blocked with 1% BSA in PBS for 40 minutes and 
stained with anti-syndecan-1 (12765; Santa Cruz Biotechnology, Inc.) and anti-GFP rabbit 
(ab6556; Abcam, Inc.) primary antibodies diluted in PBS with 1% BSA overnight at 4°C. 
The cells were then rinsed with PBS for 10 minutes three times. Secondary antibodies 
conjugated to fluorophores were added at 1:1000 dilution in 1% BSA in PBS containing 1 
μg/ml of DAPI for nuclear staining. After 75 minutes of incubation at room temperature, 
the cells were rinsed extensively with repeated PBS washes. The coverslips were mounted 
onto glass slides with anti-fade mounting media (Vector Laboratories, Inc.). Fixed cells 
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were imaged using a Fluoview FV10i confocal microscope (Olympus) at 60x 
magnification with oil immersion.  
4.2.7.  Western blot 
Cells were washed twice with cold PBS and lysed with RIPA buffer supplemented 
with 5 mM EDTA and protease and phosphatase inhibitor cocktail. Lysates were sonicated 
for 1 min, followed by centrifugation at 14,000 x g for 15 min. The supernatant was 
collected, and proteins were separated by Bis-Tris gradient (4-12%) gel and transferred 
onto nitrocellulose membranes. Membranes were blocked in 5% blocker-PBST and 
incubated with anti-Syndecan-1 antibody (2357; Santa Cruz Biotechnology, Inc.) at room 
temperature for 2 hours. Immuno-complexes were detected by applying enhanced 
chemiluminescent substrate (34096; ThermoFisher) to the membranes for 1 minute and 
immediately imaged using the GBox Chemi XX6 Imager.  
4.2.8. Drug treatment 
Cells were treated for 20 min with 1 μM latrunculin A in a final DMSO dilution of 
1:1000. 
4.2.9.  Substrates 
Glass coverslips. Unless otherwise noted, glass-coverslip-bottom 35 mm petri 
dishes were used for FRET imaging. Coverslips were coated with a solution of 11% (w/v) 
type I collagen overnight to facilitate cell attachment. 
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Substrates of varying compliance. Hydrogels (elastic moduli of 0.2 kPa and 25 
kPa) bound to glass coverslips and pre-coated with type I collagen by the manufacturer 
were utilized. 24-48 hours after seeding, the coverslips were gently rinsed with warm PBS 
and Tyrode’s solution and inverted onto a glass-coverslip with additional Tyrode’s solution 
for sensitized emission imaging.   
Micropatterns. Micropatterned glass coverslip chips (CYTOOchip, Cytoo) 
containing crossbows and Y shapes accommodating 700, 1100 and 1600 μm2 of cell area 
(large, medium and small, respectively) were coated with 20 μg/ml type I rat tail collagen 
according to the manufacturer’s instructions and seeded with 20,000 cells/ml and 4 
ml/chip. Between 1.5 and 4 hours after seeding, micropatterned coverslips were transferred 
to a proprietary chip holder and gently rinsed with warm PBS.  
Nanopatterned materials. Nanopatterned substrates were fabricated from a 
polyurethane acrylate (PUA) precursor, as described previously.(D. H. Kim et al., 2009) 
Briefly, an adhesion promoter (Minuta Tech) was applied to the glass coverslips by spin 
coating at 2000 rpm for 20 seconds and the coverslips were then baked at 65°C for 20 min. 
A PUA-based polymer of commercially characterized stiffness (6.7 MPa or 2.4 GPa) was 
then spin coated onto the glass substrate and a PDMS mold with nanogrooves having an 
800:800 nm groove:gap ratio with a 400 nm groove depth was placed on top of the PUA 
precursor layer. For nonpatterned surfaces, a mold with no features was placed on the 
polymer layer. Through capillary action, the polymer fills the mold and a nanopatterned 
surface is obtained.  The patterns were UV cured using a wavelength of 365 nm for 60 
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seconds. The substrates were then placed into well plates and plasma coated to facilitate 
protein adsorption. The substrates were then coated with a solution of 11% (w/v) type I 
collagen overnight to facilitate cell attachment. 
4.2.10. Sensitized emission FRET evaluation 
Cell culture media was replaced with warm PBS, followed by warm HEPES-
buffered Tyrode’s solution (Alfa Aesar). Sensitized emission imaging was performed using 
a Zeiss 710 confocal microscope at 40x magnification with immersion oil on a stage heated 
to 37°C. An HFT 458/514 beam splitter was used. For sensitized emission analysis, three 
images were obtained. For the donor (mTFP1) channel image, cells were excited with a 
458 nm laser and emission was collected between 470-499 nm. For the acceptor (Venus) 
channel image, excitation was performed with a 514 nm laser and emission was collected 
between 530-600 nm. The FRET channel image was obtained using excitation of the donor 
and acceptor emission. Z-stacks were obtained in 0.50 μm steps. For drug treatment 
experiments, sensitized emission imaging was performed prior to drug treatment for 
baseline FRET measurements. Imaging was performed 20 min following drug treatment 
on the same cell.   
4.2.11. FRET analysis and image processing 
Donor, acceptor and FRET images were loaded into the FRET Analyzer and 
Colocalization Analyzer plugin for Fiji (Hachet-Haas et al., 2006). Bleed-through 
correction was performed using the SDC1M (donor-only) and SDC1V (acceptor-only) cell 
lines cultured on the various substrates utilized. For each slice in a z-stack, apparent FRET 
 62 
from non-colocalized mTFP and Venus were removed within the plugin. For cells cultured 
on the nanopatterned substrate, which produces autofluorescence, background-subtraction 
for each channel and z-position was performed before FRET-indexed images were 
generated. The default “Fire” lookup table (LUT) assigned by the plugin was changed to a 
modified “Jet” LUT. Z-stacks, z-projections, side views and 3D projections were created 
using Fiji software. Surface- and substrate-level z-slices were determined by evaluation of 
side views. Z-projections were generated by average intensity. Masks were created in 
Photoshop (Adobe) using Venus channel images to distinguish zero-FRET from regions 
where the sensor was not present.  
4.2.12.  FRET index quantification from images 
Substrate-level and surface-level slices were identified from orthogonal views of z-
stacks, and average z-projections were generated. For the quantification of FRET index, 
cells were subdivided lengthwise, and the first and last third of the cell was traced, avoiding 
the nucleus. The mean FRET index was obtained from these traced regions. For cells grown 
on substrates of varying stiffness, FRET index was measured instead from side views (in 
triplicate) due to deformation of 0.2 kPa substrates by the cells. For profile scans of cells 
grown on crossbow micropatterns and nanopatterned substrates, a 10-pixel tall region 
spanning the cell was drawn perpendicular to the micropattern or the direction of the 
nanopattern. For treatment experiments and shear stress experiments, relative FRET index 
was calculated by normalizing to baseline FRET index measurements of the same cell. 
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4.2.13.  Statistical analysis 
All results are shown as mean ± standard error of the mean. Comparisons between 
only two groups were performed using a Mann-Whitney test. Differences were considered 
significant at p<0.05. Multiple comparisons between groups were analyzed by a two-way 
ANOVA, followed by Dunnett’s post-hoc test. A 2-tailed probability value <0.05 was 
considered statistically significant. 
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4.3   RESULTS 
4.3.1. Localization of the SDC1 tension sensor 
To validate whether the SDC1-TS localized properly within the cell, we 
immunostained non-transduced HUVECs and HUVECs expressing the SDC1-TS, 
TSΔEcto, TSΔGAG and TSΔCyto for Venus and SDC1. Although staining for SDC1 
labels both native SDC1 and the tension sensors, it confirmed that the TS, TSΔEcto and 
TSΔGAG localize within the cell as expected. However, the TSΔCyto accumulates around 
and depresses the nucleus (Figure 4.2). 
4.3.2. Western blot 
Western blot analysis confirmed the expected sizes for the SDC1-TS and mutant 
versions of the TS (Figures 4.3-4.4).  
4.3.3. The SDC1 tension sensor is under higher tension than the ectodomain mutant 
sensor. 
We cultured cells expressing the tension sensors, evaluated FRET using sensitized 
emission, imaging through the entire height of the cells (Figure 4.5A, C). This enabled the 
separation of surface-depth FRET, as well as substrate-depth FRET. At the surface level, 
tension on TSΔEcto was significantly lower than the complete SDC1-TS, as indicated by 
increased FRET index. At the substrate level, tension on TSΔEcto and TSΔGAG was lower 
than the complete SDC1-TS. However, tension on TSΔGAG at the surface level was 
similar to that of SDC1-TS at the surface level (Figure 4.5B). Under these baseline 
conditions, there were no significant differences in FRET index between the surface and 
substrate levels for any given sensor. 
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4.3.4. Cytoskeletal disruption reduces SDC1 tension. 
As SDC1 is linked directly to the cytoskeleton via its cytoplasmic domain, we 
considered that cytoskeletal tension could influence SDC1 tension.(Carey, Bendt, & Stahl, 
1996) To test whether the tension sensors respond to changes in cytoskeletal tension, we 
disrupted the cytoskeleton by treatment with 1 μM latrunculin A, observing increases in 
FRET for the SDC1-TS, TSΔEcto and TSΔGAG (Figure 4.6A-B). This increase in FRET 
was not exhibited by the TSΔCyto sensor.  
4.3.5. Substrate compliance modulates SDC1 tension. 
Our previous work indicated that SDC1 is important for smooth muscle cell 
mechanosensation of substrate stiffness. To examine if substrate compliance modulates 
tension on SDC1, itself, we cultured cells expressing the TS and mutant versions of the 
tension sensor onto collagen type I-coated hydrogels with elastic moduli of 0.2 or 25 kPa 
and evaluated FRET (Figure 4.7A-B). Cells expressing the SDC1-TS, TSΔEcto and 
TSΔCyto exhibited significantly higher tension (lower FRET) across the sensors when 
cultured on the 25 kPa substrate, compared to those cultured on the 0.2 kPa substrate. 
TSΔGAG exhibited no significant change in tension in response to substrate compliance. 
Compared to SDC1-TS, higher tension was observed in TSΔGAG on the 0.2 kPa substrate. 
TSΔCyto exhibited higher tension compared to SDC1-TS on the 25 kPa substrate (Figure 
4.7B).  
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4.3.6.  SDC1 tension is increased in regions of cellular adhesion. 
SDC1 is known to cluster and turnover in focal adhesions.(Altemeier, Schlesinger, 
Buell, Parks, & Chen, 2012) Our observation that TSΔGAG is under less tension that 
SDC1-TS at the substrate level, under baseline conditions, led us to ask whether adhesion 
to the ECM contributes to SDC1 tension. To examine the response of SDC1 tension to 
regions of cellular adhesion, we utilized micropatterned chips (Cytoo), which spatially 
control adhesion at the level of a single cell. We cultured cells expressing the SDC1-TS 
and mutant versions of the sensor onto type I collagen crossbow and Y-shaped 
micropatterns, which are adhesive but surrounded by a non-adhesive coating (Figure 
4.8A). We then evaluated FRET at the level of the micropattern (Figure 4.8B). Profile 
scans through FRET index images of cells cultured on the 1100 um2 (medium) crossbow 
micropatterns (Figure 4.9A) indicated decreased FRET for SDC1-TS over adhesive 
regions (Figure 4.9B).  The ratio of adhered-FRET and unadhered FRET for SDC1-TS 
was decreased in SDC1-TS compared to TSΔEcto on crossbows (Figure 4.10A).  
4.3.8. SDC1 tension increases in response to nanogrooves.  
Our previous work showed that the loss of SDC1 alters the mechanosensation of 
substrate stiffness and nanotopography. To understand how nanopatterning affects SDC1 
tension, we cultured cells expressing the SDC1-TS and mutant versions of the sensor onto 
type I collagen-coated 2.4 GPa unpatterned (flat) and nanopatterned substrates and 
evaluated FRET (Figure 4.11A-C). FRET profiles of the substrate-level of the cell, 
perpendicular to the direction of the nanogrooves, revealed increased tension on SDC1-TS 
in regions of the cell adhered to the peaks of the nanopattern, compared to SDC1-TS on 
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the flat substrate (Figure 4.12A).  Overall, nanopatterning increased tension on SDC1 
(Figure 4.13). TSΔEcto and TSΔGAG on nanopatterned substrates exhibited decreased 
tension compared to SDC1-TS on the same substrate, while TSΔCyto exhibited increased 
tension. On flat substrates, only TSΔGAG and TSΔCyto exhibited increased tension 




Figure 4.1. Diagram of SDC1 tension sensors. (A) Human SDC1 protein. (B) A FRET 
construct was inserted into the extracellular domain of SDC1 to create the SDC1 tension 
sensor (TS). An ectodomain mutant (ΔEcto), glycosaminoglycan attachment site mutant 
(ΔGAG) and cytoplasmic domain mutant (ΔCyto) were created to investigate SDC1 
subdomains in tension propagation. (C) Donor- and acceptor-only controls for bleed-




Figure 4.2. Representative immunostaining for GFP family and SDC1. Localization of 
the tension sensing construct (GFP family) and SDC1 within non-transduced human 
umbilical vein endothelial cells (HUVECs) and HUVECs expressing the SDC1 tension 
sensor (TS), ectodomain mutant (ΔEcto), glycosaminoglycan attachment site mutant 




Figure 4.3. Western blot for SDC1. Non-transduced human umbilical vein endothelial 
cells (HUVECs) (WT), HUVECs expressing acceptor only (V) and donor only (M) bleed-
through controls, SDC1 tension sensor (TS), ectodomain mutant (ΔE), glycosaminoglycan 











Figure 4.4. Western blot for Venus. Non-transduced HUVECs (WT), HUVECs 
expressing acceptor only (V) and donor only (M) bleed-through controls, syndecan-1 
tension sensor (TS), ectodomain mutant (ΔE), glycosaminoglycan chain attachment site 




Figure 4.5. Baseline FRET in SDC1 tension sensor and mutant sensors. (A) 
Representative surface- and substrate-level z-projected FRET index images of cells 
expressing the SDC1 tension sensor (TS), ectodomain mutant (ΔEcto), glycosaminoglycan 
chain attachment site mutant (ΔGAG) and cytoplasmic domain mutant (ΔCyto). Bar = 50 
μm. (B) Quantification of FRET index at the surface and substrate levels. †p<0.05 versus 





Figure 4.6. Cytoskeletal disruption decreases tension on SDC1 tension sensor. Cells 
expressing the SDC1 tension sensor (TS), ectodomain mutant (ΔEcto), glycosaminoglycan 
chain attachment site mutant (ΔGAG) and cytoplasmic domain mutant (ΔCyto) were 
treated with 1 μM latrunculin A (LatA). (A) Representative FRET index images. (B) 




Figure 4.7. Tension on SDC1 tension sensor decreases in response to decreased 
substrate compliance. Cells expressing the SDC1 tension sensor (TS), ectodomain mutant 
(ΔEcto), glycosaminoglycan attachment site mutant (ΔGAG) and cytoplasmic domain 
mutant (ΔCyto) were cultured on 0.2 kPa and 25 kPa hydrogels coated with collagen type 
I. (A) Representative maximum z-projected FRET index images. (B) Side views. Bars = 
50 μm. (B) Quantification of surface- and substrate-level FRET indices. *p<0.05 versus 
cells expressing the same sensor, cultured on 0.2 kPa substrate. †p<0.05 versus TS cells 
cultured on the same substrate. n = 10. 
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Figure 4.8. Tension on SDC1 is increased in regions of cellular adhesion.  Human 
umbilical vein endothelial cells (HUVECs) expressing the SDC1 tension sensor (TS), 
ectodomain mutant (ΔEcto), glycosaminoglycan attachment site mutant (ΔGAG) and 
cytoplasmic domain mutant (ΔCyto) were cultured onto micropatterned substrates and 
evaluated for FRET. (A) Diagram of crossbow and Y-shaped micropatterns. Black, non-
adherent regions. Gray, adherent regions coated with collagen type I.  (B) Representative 




Figure 4.9. Tension sensor FRET profiles in response to micropatterning. Human 
umbilical vein endothelial cells (HUVECs) expressing the SDC1 tension sensor (TS), 
ectodomain mutant (ΔEcto), glycosaminoglycan attachment site mutant (ΔGAG) and 
cytoplasmic domain mutant (ΔCyto) were cultured onto crossbow micropatterns and 
evaluated for FRET. (A) Example profile scan area for FRET index image of cell adhered 
to 1100 um2 crossbow. Bar = 25 μm. (B) Representative substrate-level FRET index 
profiles. Black, non-adherent regions. Gray, adherent regions.  
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Figure 4.10.  Tension on SDC1 is increased in regions of cellular adhesion compared 
to regions of non-adherence. Human umbilical vein endothelial cells (HUVECs) 
expressing the SDC1 tension sensor (TS), ectodomain mutant (ΔEcto), glycosaminoglycan 
attachment site mutant (ΔGAG) and cytoplasmic domain mutant (ΔCyto) were cultured 
onto crossbow and Y-shaped micropatterns. Quantification of FRET in regions of 
adhesion, ratioed to FRET in regions of non-adherence for cells cultured on (A) crossbow 





Figure 4.11. Nanogrooves alter tension on SDC1. Human umbilical vein endothelial 
cells (HUVECs) expressing the SDC1 tension sensor (TS), ectodomain mutant (ΔEcto), 
glycosaminoglycan mutant (ΔGAG) and cytoplasmic domain mutant (ΔCyto) were 
cultured onto unpatterned (flat) and nanogrooved (nano) substrates of 2.4 GPa stiffness. 
Representative (A) substrate and (B) surface-level z-projections of FRET index images. 




Figure 4.12. Profiles of substrate-level FRET in response to nanogrooves. Human 
umbilical vein endothelial cells (HUVECs) expressing the SDC1 tension sensor (TS), 
ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and cytoplasmic domain 
mutant (ΔCyto) were cultured onto unpatterned (flat) and nanogrooved (nano) substrates 
of 2.4 GPa stiffness. Representative FRET profiles of substrate-level z-projections, 
perpendicular to the direction of the nanopattern for cells expressing the (A) TS, (B) ΔEcto, 




Figure 4.13. SDC1 tension is increased at the substrate level in response to 
nanogrooves. Human umbilical vein endothelial cells (HUVECs) expressing the SDC1 
tension sensor (TS), ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and 
cytoplasmic domain mutant (ΔCyto) were cultured onto unpatterned (flat) and 
nanogrooved (nano) substrates of 2.4 GPa stiffness. (A) Quantification of average FRET 
from FRET profiles at the substrate-level. *p<0.05 versus TS on same substrate. †p<0.05 





Figure 4.14. Profiles of surface-level FRET in response to nanogrooves. Human 
umbilical vein endothelial cells (HUVECs) expressing the SDC1 tension sensor (TS), 
ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and cytoplasmic domain 
mutant (ΔCyto) were cultured onto unpatterned (flat) and nanogrooved (nano) substrates 
of 2.4 GPa stiffness. Representative FRET profiles of surface-level z-projections, 
perpendicular to the direction of the nanopattern for cells expressing the (A) TS, (B) ΔEcto, 





Figure 4.15. Model of SDC1 tension response to 2.4 GPa nanogrooves.  
 83 
4.4 DISCUSSION 
 This work provides evidence that tension on SDC1 is modulated by biophysical 
cues. SDC1 interacts with numerous proteins via its extracellular domain. The vast 
majority of SDC1’s direct protein contacts occur via its extracellular domain, and in 
particular, the long GAG chains bound to its core ectodomain.  
Our finding that SDC1 intension, itself, is responsive to substrate stiffness is 
consistent with our previous work, which found that SDC1 is involved in the 
mechanosensation of substrate stiffness.(Le et al., 2018) Previous work from other groups 
indicated that integrin αVβ3, which is regulated by SDC1, (McQuade et al., 2006) has been 
implicated as involved in mechanosensation of substrate stiffness.(Jiang, Huang, Cai, 
Tanase, & Sheetz, 2006) SDC1 is also responsive to the microenvironment of cancer cells 
(Chute et al., 2018; Su, Blaine, Qiao, & Friedl, 2007) and even modulate tissue 
stiffness.(Chute, Keely, Alexander, & Friedl, 2013)  
Under baseline conditions, decreased tension at the substrate level and similar 
tension at the surface level for TSΔGAG compared to the complete sensor suggest that the 
GAG chains are required for SDC1 tension at the substrate level, but are not important for 
SDC1 tension at the surface level. This is consistent with the known direct binding of the 
heparan sulfate chains to the extracellular matrix.  (Eriksson & Spillmann, 2012; Koda, 
Rapraeger, & Bernfield, 1985; Mattson et al., 2017; Vuoriluoto et al., 2008) Interestingly, 
loss of the cytoplasmic domain, and thus direct association with the cytoskeleton, did not 
abolish tension on SDC1 suggesting that SDC1 does not require a direct linkage to the 
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cytoskeleton for tension propagation. As SDC1 is linked indirectly to the cytoskeleton by 
other means(Beauvais et al., 2004; Beauvais & Rapraeger, 2003), exploration of the role 
of the αV integrins in SDC1 tension propagation is warranted. The reduced FRET observed 
in TSΔCyto may also be due to changes in localization of the sensor as a result of the loss 
of the cytoplasmic domain, misfolding of the sensor or decreased expression levels. 
Our finding that SDC1-TS located in adhered regions of the cell is under higher 
tension indicates that the link between the ECM and SDC1 is important for SDC1 tension. 
When we cultured the cells expressing the tension sensors onto compliant substrates, we 
observed no significant difference in tension between TSΔGAG adhered to 0.2 kPa and 25 
kPa substrates. This is consistent with our baseline FRET observations for TSΔGAG. 
Taken together, these findings are suggestive of a model in which SDC1 tension increases 
during adhesion. Interestingly, TSΔEcto was responsive to change in substrate compliance, 
suggesting that the TSΔEcto sensor is under compression on the 25 kPa substrate.  
In Aim 1, we observed based on increases in Yap/Taz and Rock1 that S1KO vSMCs 
are under more tension when adhered to nanopatterns. Here, the alternating FRET index 
pattern we observe for SDC1-TS on nanopatterned substrates could be indicative of 
alternating high and low tension or alternating high tension and compression. We observed 
that SDC1 tension is higher within nanogrooves and decreased in the regions of the 
nanopattern peaks (Figure 4.15), which is consistent with a model in which the cell is 
pulling back with more force on nanopatterning. This may be due to the presence of more 
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adhesion sites per unit area TSΔGAG tension on the flat substrate is similar to TSΔGAG 




Chapter 5. Mechanisms of Syndecan-1 Tension Sensing 
5.1   INTRODUCTION 
We recently created and validated a FRET-based SDC1-TS that enabled the 
visualization of SDC1 tension in response to substrate-mediated cues. In Chapter 4, we 
found that tension on SDC1 increases upon binding with the substrate and that flexible 
substrates reduce SDC1 tension. Here, we explored the mechanisms of SDC1 tension, 
examining the relationships between SDC1 tension, its integrin binding partners, Rho-
mediated cytoskeletal tension and focal adhesion formation. We also examined the 
response of SDC1 tension to fluidic shear stress and endothelial tube formation.  
SDC1 is known to bind and regulate integrins αVβ3 and αVβ5. Upon clustering 
with SDC1 and IGF-1R, this complex affects such processes as cell survival, angiogenesis 
and metastasis.(Beauvais & Rapraeger, 2003; Rapraeger, 2013) When the interaction of 
SDC1 with the αV is disrupted with synstatin, a peptide derived from SDC1, cell spreading 
is reduced.(Beauvais et al., 2009) This suggested to us that the αV might contribute to 
SDC1 tension. In our original design of the SDC1 tension sensor, we positioned the mTFP-
elastic linker-Venus FRET construct in the ectodomain of SDC1, just before the docking 
site for the αV integrins. Our ectodomain mutant of the SDC1-TS, SDC1-TSΔEcto, lacks 






5.2   MATERIALS AND METHODS 
5.2.1. Cell culture 
Human umbilical vein endothelial cells (HUVECs) from a single donor (Lonza, 
#C-11200) were cultured in MCDB-131 culture medium (Gibco) with 7.5% fetal bovine 
serum (FBS), endothelial cell growth supplement (R&D Systems), L-glutamine and 
antibiotics. 
5.2.2. Cell lines 
 HUVECs expressing the SDC1-TS, SDC1-TSΔEcto, SDC1-TSΔGAG, SDC1-
TSΔCyto, created in Chapter 4, were used in the studies. HUVECs expressing only mTFP 
or only Venus were used for bleed-through correction of FRET indexing. 
5.2.3. Sensitized emission evaluation of FRET  
Cell culture media was replaced with warm PBS, followed by warm HEPES-
buffered Tyrode’s solution (Alfa Aesar). Sensitized emission imaging was performed using 
a Zeiss 710 confocal microscope at 40x magnification with immersion oil on a stage heated 
to 37°C. An HFT 458/514 beam splitter was used. For sensitized emission analysis, three 
images were obtained. For the donor (mTFP1) channel image, cells were excited with a 
458 nm laser and emission was collected between 470-499 nm. For the acceptor (Venus) 
channel image, excitation was performed with a 514 nm laser and emission was collected 
between 530-600 nm. The FRET channel image was obtained using excitation of the donor 
and acceptor emission. Z-stacks were obtained in 0.50 μm steps. For drug treatment 
experiments, sensitized emission imaging was performed prior to drug treatment for 
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baseline FRET measurements. Imaging was performed 20 min following drug treatment 
on the same cell.   
5.2.4. FRET analysis and image processing 
Donor, acceptor and FRET images were loaded into the FRET Analyzer and 
Colocalization Analyzer plugin for Fiji (Hachet-Haas et al., 2006). Bleed-through 
correction was performed using the Sdc1M (donor-only) and Sdc1V (acceptor-only) cell 
lines cultured on the various substrates utilized. For each slice in a z-stack, apparent FRET 
from non-colocalized mTFP and Venus were removed within the plugin. For cells cultured 
on the nanopatterned substrate, which produces autofluorescence, background-subtraction 
for each channel and z-position was performed before FRET-indexed images were 
generated. The default “Fire” lookup table (LUT) assigned by the plugin was changed to a 
modified “Jet” LUT. Z-stacks, z-projections, side views and 3D projections were created 
using Fiji software. Z-projections were generated by average intensity. Masks were created 
in Photoshop (Adobe) using Venus channel images to distinguish zero-FRET from regions 
where the sensor was not present. 
5.2.5.  FRET index quantification from images 
Substrate-level and surface-level slices were identified from orthogonal views of z-
stacks, and average z-projections were generated. For the quantification of FRET index, 
cells were subdivided lengthwise, and the first and last third of the cell was traced, avoiding 
the nucleus. The mean FRET index was obtained from these traced regions. For shear stress 
experiments, FRET index was measured from the first (upstream) and last (downstream) 
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quarter of the cell in the direction of flow from side views, in triplicate. For treatment 
experiments and shear stress experiments, relative FRET index was calculated by 
normalizing to baseline FRET index measurements of the same cell. 
5.2.6.  Drug treatment  
Cells were treated for 20 minutes using the drugs shown in Table 5.1.  The synstatin 
peptide encompasses amino acids 93-120 of human SDC1.(Rapraeger, 2013) 
Table 5.1. Drug Treatments 
Drug Conc. (μM) Vendor 
(+)-Blebbistatin* 50 EMD Millipore 
(-)-Blebbistatin* 50 EMD Millipore 
PF-573,228* 10 Tocris 
PP2* 50 Sigma-Aldrich 
Y27632* 10 Sigma-Aldrich 
Manganese chloride tetrahydrate 0.5 Sigma-Aldrich 
Synstatin 1 Genscript 
Cilengitide 10 R&D Systems 
* denotes 1:1000 DMSO dilution during treatment 
 
5.2.7. Tube formation experiments 
Chilled Matrigel (25 μl; Corning) was applied to coverslip glass bottom 35 mm 
dishes on ice and spread using a cell scraper to create a thin-layer of basement matrix and 
then incubated for 30 minutes at 37°C, adapted from the method described by Faulkner and 
others (2014) (Faulkner et al., 2014). Cells were seeded at 2,500 cells/cm2 onto the Matrigel 
in DMEM medium with 7.5% fetal bovine serum, L-glutamine, penicillin-streptomycin, 
100 ng/ml VEGF and 10 ng/ml FGF-2. Immediately before imaging, the medium was 
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gently replaced with warm PBS, followed by warm Tyrode’s solution. Sensitized emission 
imaging was performed 4, 6- and 8-hours following seeding. 
5.2.8. Application of shear stress  
Slides containing six flow channels (μ-slide, IBIDI) were coated with type I rat tail 
collagen overnight and seeded with HUVECs expressing SDC1-TS. The cell culture 
medium was aspirated and replaced with Tyrode’s solution (Alfa-Aesar) pre-warmed to 
37°C. Sixty-ml syringes (BD) with an inner diameter of 26.72 mm and silicone tubing were 
also filled with pre-warmed Tyrode’s solution. Shear stress was applied to the channels 
using a syringe pump (KD Scientific). Sensitized emission imaging of cells under static 
conditions was performed with the flow system attached to the channels but without the 
induction of flow. Following imaging under static conditions, flow was initiated, and 
sensitized emission imaging was immediately repeated under static (static-static) or flow 
conditions (static-12 dynes/cm2). For 12 dynes/cm2 shear stress, 9.46 ml/min flow was 
used, distributed across three syringes connected to the inflow via a syringe scaffold. The 
resulting sets of images for the static-static experiment were designated as: 1) Baseline 
FRET and 2) Static FRET. The sets of images for the static-flow experiment were 
designated as: 1) Baseline FRET and 2) Flow FRET. 
5.2.9. Quantification of FRET under shear stress 
Three orthogonal slices were obtained from the z-stacks, through the nucleus of 
each cell, in the direction of flow. The length of each cell was sub-divided into fourths, 
with the first and fourth segments designated as the upstream and downstream lengths of 
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the cell. The first and fourth segments were further sub-divided into a substrate and surface-
level areas, resulting in regions designated as upstream surface-level, upstream substrate-
level, downstream surface-level and downstream substrate-level (Figure 5.14A). These 
regions were traced in Fiji software and the mean FRET index were obtained for each.  
For each cell in the static-static experiments, Static FRET was divided by Baseline 
FRET to obtain Rel. Static FRET for that cell. The Rel. Static FRET for that cell was 
divided by the average Rel. Static FRET for the entire group to obtain Normalized Static 
FRET. Similarly, for each cell in the static-flow experiments, Flow FRET was divided by 
Baseline FRET to obtain Rel. Flow FRET for that cell. The Rel. Flow FRET for that cell 
was divided by the average Rel. Static FRET for the entire static-static group to obtain 
Normalized Flow FRET.  
5.2.10. Statistical analysis 
All results are shown as mean ± standard error of the mean. Comparisons between 
only two groups, for which relative FRET is shown (normalized to baseline FRET), were 
performed using a Wilcoxon matched-pairs signed rank test. Differences were considered 
significant at p<0.05. Comparisons between only two unpaired groups with relative FRET 
values, were performed using a Mann-Whitney test. Differences were considered 
significant at p<0.05. Multiple comparisons between groups were analyzed by a Kruskal-
Wallis test followed by Dunn’s post-hoc test. A 2-tailed probability value <0.05 was 
considered statistically significant. 
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5.3   RESULTS 
5.3.1. Integrin activation with manganese increases SDC1 mechanical tension. 
SDC1 activates and directly interacts with integrins αVβ3 and αVβ5 and inhibition 
of this interaction has been shown to reduce cell spreading.(Beauvais et al., 2009) For this 
reason, we wanted to examine whether integrins influence SDC1 tension. To determine the 
response of the SDC1-TS to integrin activation, we treated cells expressing the TS and 
mutant versions of the TS with manganese, which induces the activation and clustering of 
integrins (Cluzel et al., 2005; Mould et al., 2002) (Figures 5.1-5.2). We then evaluated the 
FRET response to manganese treatment, relative to FRET under the baseline untreated 
conditions. Integrin activation markedly increased tension on the TS at the surface level of 
the cell. All other sensors demonstrated increased tension at the substrate level. No 
difference in response to integrin activation was observed between the surface and 
substrate for any sensor (Figure 5.3).   
5.3.2. DMSO treatment increases tension on SDC1.  
We performed 1:1000 DMSO treatments as a number of the drug treatments in this 
study are solubilized in DMSO, finding that DMSO, itself, causes increased FRET (Figure 
5.4A, C). Both the surface and substrate level demonstrated a marked decrease in FRET, 
compared to pre-treatment FRET (Figure 5.4B). For this reason, we began performing an 
additive correction to post-treatment relative FRET values for those treatments solubilized 
in DMSO: Y-27632, PF-573,228, PP2 and (-)-Blebbistatin. 
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5.3.3. Inhibition of rho-associated protein kinase decreases SDC1 mechanical tension 
at the surface level.  
To understand the modulation of SDC1 by Rho-mediated cytoskeletal tension, we 
treated cells expressing the TS with the rho-associated protein kinase (ROCK) inhibitor Y-
27632 (Figure 5.5A-B). We observed a slight decrease in SDC1 tension at the surface level 
of the cell, relative to baseline conditions and with correction for the FRET-decreasing 
effect of DMSO treatment alone. (Figure 5.5C).  
5.3.4. Focal adhesion kinase (FAK) inhibition increases surface-level SDC1 tension.   
To examine the effect of FAK inhibition on SDC1 tension, we treated cells 
expressing the SDC1-TS with 10 μM PF-573,228 (Figure 5.6A, C).(Golubovskaya et al., 
2012) Surface-level SDC1-TS tension increased in response to treatment, relative to 
baseline conditions and with correction for the FRET-decreasing effect of DMSO treatment 
alone (Figure 5.6B).  
5.3.5. Response of SDC1 tension to Src-family kinase inhibition 
We observed no significant change in SDC1-TS FRET at either the surface or the 
substrate level in response to treatment with 50 μM PP2, an inhibitor of Src-family 
kinases.(Nerlich et al., 2009; Orlandini et al., 2008)  
5.3.6. Response of SDC1 tension to myosin ii inhibition 
We treated cells expressing the SDC1-TS with the inactive enantiomer (+)-
Blebbistatin (Bleb) and the active enantiomer (-)-Blebbistatin (Figure 5.8A-B, 
C).(Chervin-Petinot et al., 2012) After adjustment for the change in FRET due to (+)-Bleb 
 94 
in DMSO, tension on the SDC1-TS was not significantly affected by myosin ii inhibition 
(Figure 5.8B). 
5.3.7. Inhibition of SDC1 interaction with integrins increases SDC1 tension.  
To inhibit the interaction of SDC1 with αVβ3 and αVβ5, we treated cells expressing 
SDC1-TS and TSΔEcto with a peptide derived from the docking site for integrins on SDC1, 
synstatin (SSTN) (Figure 5.9A-B, D).(Rapraeger, 2013) SSTN treatment increased tension 
on both SDC1-TS and SDC1-TSΔEcto at the surface level and the substrate level, 
compared to baseline tension. For the SDC1-TS, the relative change in tension in response 
to SSTN treatment did not significantly differ between the surface level and the substrate 
level (Figure 5.9C).  
5.3.8. Inhibition of αv integrins increases substrate-level SDC1 tension.  
Cilengitide blocks the activation of the αv integrins.  We treated cells expressing 
the SDC1-TS and TSΔEcto with cilengitide (CLGT), (Figure 5.10A-B, D). CLGT 
treatment significantly increased tension on SDC1 at the substrate level, but did not affect 
surface-level SDC1 tension. For SDC1-TS, the relative change in tension in response to 
CLGT was significantly greater at the substrate level than the surface level (Figure 5.10C).  
5.3.9. Fluidic shear stress alters the distribution of SDC1 tension on endothelial cells. 
Vascular endothelial cells are subject to fluidic shear stress, which influences 
vascular remodeling, and protect against or promote atherosclerosis. Previous work from 
our group found that the loss of SDC1 alters the shear stress-induced activation of Akt 
signaling, as well as shear stress-induced intracellular spatial gradients of phosphorylated 
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paxillin. Additionally, the activation of RhoA in response to shear stress was reduced in 
S1KO knockout endothelial cells, compared to wild-type cells. These findings are 
suggestive a role for SDC1 in the mechanosensation of shear stress.(Voyvodic et al., 2014)  
To examine how tension across SDC1 responds to shear stress, we seeded HUVECs 
expressing the TS and mutant versions of the TS on microchannels and subjected them to 
baseline static conditions, followed by static (static-static) or 12 dynes/cm2 of shear stress 
(static-flow) (Figures 5.11A, 5.12A) , performing FRET imaging during each condition 
(Figures 5.11B-C, 5.12B-C, 5.13) . During our analysis, we subdivided cells into four 
regions with respect to the direction of flow: upstream surface level, upstream substrate 
level, downstream surface level and downstream substrate level (Figure 5.14A). In 
response to flow, TS cells exhibited an increase in tension on the upstream cellular surface 
and upstream substrate level in response to flow, relative to FRET at baseline static. In 
those regions, the TSΔGAG also exhibited an increase in tension in response to flow 
(Figure 5.14B, C). At the downstream surface level of the cell, the TSΔCyto sensor 
exhibited compression in response to flow (Figure 5.14C). Interestingly, marked 
compression was observed at the downstream substrate level of TS cells in response to 
flow. In this region, TSΔEcto and TSΔGAG exhibited no change in tension in response to 
flow, and their FRET response under flow differed significantly from SDC1-TS. The 
cytoplasmic domain mutant of the TS exhibited compression (Figure 5.1E). 
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5.3.10. Tension on SDC1 is altered during endothelial tube formation.  
 To determine if SDC1 tension is affected by endothelial tube formation, we induced 
tube formation in HUVECs expressing the SDC1-TS and evaluated FRET over the first 
eight hours. SDC1 was under high tension throughout this period, but decreased SDC1 




Figure 5.1. FRET response of SDC1 tension sensor to integrin activation using 
manganese. Human umbilical vein endothelial cells (HUVECs) expressing the SDC1 
tension sensor (TS), ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and 
cytoplasmic domain mutant (ΔCyto) were evaluated for FRET before and after treatment 
with 0.5 μM Mn2+. Representative (A) surface- and (B) substrate-level z-projected FRET 




Figure 5.2. FRET response of SDC1 tension sensor to integrin activation using 
manganese. Human umbilical vein endothelial cells (HUVECs) expressing the SDC1 
tension sensor (TS), ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and 
cytoplasmic domain mutant (ΔCyto) were evaluated for FRET before and after treatment 




Figure 5.3. Integrin activation using manganese increases tension on SDC1. Human 
umbilical vein endothelial cells (HUVECs) expressing the SDC1 tension sensor (TS), 
ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and cytoplasmic domain 
mutant (ΔCyto) were evaluated for FRET before and after treatment with 0.5 μM Mn2+. 
Quantification of surface and substrate-level FRET indices after Mn2+ treatment, relative 





Figure 5.4. DMSO increases tension on SDC1. (A) Representative surface- and 
substrate-level, z-projected FRET index images of cells expressing the SDC1-TS before 
and after treatment with 1:1000 DMSO. Bar = 50 μm. (B) Quantification of surface- and 
substrate-level FRET indices after DMSO treatment, relative to FRET indices under the 
untreated condition. *p<0.05 versus baseline untreated FRET at the same cellular level. n 





Figure 5.5. Rock inhibition increases SDC1 tension at the substrate level. (A) 
Representative surface- and substrate-level, z-projected FRET index images of cells 
expressing the SDC1-TS before and after Rock inhibition with 10 μM Y27632 in DMSO. 
Bar = 50 μm. (B) Quantification of surface- and substrate-level FRET indices after Y27632 
treatment, relative to FRET indices under the untreated condition and normalized by 
change in FRET indices under DMSO. *p< 0.05 versus baseline untreated substrate-level 
FRET. †p<0.05 versus Y27632-treated surface-level FRET. n = 6. (C) Side views. Bar = 









Figure 5.6. FAK inhibition increases surface-level SDC1 tension. (A) Representative 
surface- and substrate-level, z-projected FRET index images of cells expressing the SDC1-
TS before and after treatment with 10 μM PF-573,228 in DMSO. Bar = 50 μm. (B) 
Quantification of surface- and substrate-level FRET indices after PF-578,228 treatment, 
relative to FRET indices under the untreated condition and normalized by change in FRET 
indices under DMSO. *p<0.05 versus baseline untreated FRET at substrate level. n = 6. (C) 





Figure 5.7. Modulation of SDC1 tension by Src inhibition. (A) Representative surface- 
and substrate-level, z-projected FRET index images of cells expressing the SDC1-TS 
before and after treatment with 50 μM PP2 in DMSO. Bar = 50 μm (B) Quantification of 
surface- and substrate-level FRET indices after PP2 treatment, relative to FRET indices 
under the untreated condition and normalized by change in FRET indices under DMSO. n 





Figure 5.8. Modulation of SDC1 tension by myosin ii inhibition. Representative 
surface- and substrate-level, z-projected FRET index images of cells expressing the SDC1-
TS before and after treatment with 50 μM (A) (inactive) (+)-Blebbistatin (Bleb) or (B) 
(active) (-)-Bleb in DMSO. Bars = 50 μm (C) Quantification of surface- and substrate-level 
FRET indices after (-)-Bleb treatment, relative to FRET indices under the untreated 
condition and adjusted for change in FRET indices under (+)-Bleb in DMSO. n = 6. (D) 




Figure 5.9. Inhibition of SDC1 interaction with integrins increases SDC1 tension. 
Representative (A) surface- and (B) substrate-level, z-projected FRET index images of 
cells expressing the SDC1-TS (TS) and ectodomain mutant (ΔEcto) before and after 
treatment with 1 μM synstatin (SSTN). (C) Quantification of surface- and substrate-level 
FRET indices after SSTN treatment, relative to FRET indices under the baseline untreated 
condition. *p<0.05 versus baseline untreated FRET. †p<0.01 versus SSTN-treated surface-




Figure 5.10. Substrate-level SDC1 tension increases in response to the inhibition of αv 
integrins. Representative (A) surface- and (B) substrate-level, z-projected FRET index 
images of cells expressing the SDC1-TS (TS) and ectodomain mutant (ΔEcto) before and 
after treatment with 10 μM cilengitide (CLGT). Bars = 50 μm. (C) Quantification of 
surface- and substrate-level FRET indices after CLGT treatment, relative to FRET indices 
under the baseline untreated condition. *p<0.05 versus baseline untreated FRET. †p<0.05 




Figure 5.11. Response of SDC1 tension sensors to static-static conditions. Cells 
expressing the SDC1-TS (TS), ectodomain mutant (ΔEcto), glycosaminoglycan mutant 
(ΔGAG) and cytoplasmic domain mutant (ΔCyto) sensors were cultured in type I collagen-
coated microchannel slides and evaluated for FRET under static-static conditions. (A)  
Diagram of experiment. Representative (B) surface- and (C) substrate-level, z-projected 
FRET index images of cells expressing the sensors under an initial static condition, 




Figure 5.12. Response of SDC1 tension sensors to shear stress. Cells expressing the 
SDC1-TS (TS), ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and 
cytoplasmic domain mutant (ΔCyto) sensors were cultured in microchannel slides coated 
with collagen type I and evaluated for FRET under static conditions, followed by 12 
dynes/cm2 shear stress. (A)  Diagram of experiment. Representative (B) surface- and (C) 
substrate-level, z-projected FRET index images of cells expressing the sensors under an 




Figure 5.13. Side views of response of SDC1 tension sensors to static-static and static-
flow conditions. Representative FRET side views of cells expressing the SDC1-TS (TS), 
ectodomain mutant (ΔEcto), glycosaminoglycan mutant (ΔGAG) and cytoplasmic domain 





Figure 5.14. SDC1 compresses at the substrate level, downstream of the direction of 
flow. (A) Diagram of subdivisions of FRET index images with respect to the direction of 
flow. Quantification of FRET index at the (B) upstream surface, (C) downstream surface, 
(D) upstream surface and (E) downstream surface of the cell under static-static and static-
flow conditions, relative to FRET under the initial static condition. *p<0.05 versus baseline 




Figure 5.15. SDC1 tension during endothelial tube formation. Representative FRET 





Figure 5.16. Model of SDC1 tension response to 12 dynes/cm2 shear stress.   
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5.4   DISCUSSION 
Here, we demonstrate that integrin binding with SDC1 contributes to SDC1 tension 
and that fluidic shear stress induces a spatial gradient of SDC1 tension in response to flow. 
Removal of the glycocalyx has been shown to reduce glycocalyx reduces the shear-stress-
mediated response of endothelial cells. Because enzymatic removal of heparan sulfate is 
known to also affect the response of endothelial cells to shear-stress, heparan sulfate-
containing transmembrane proteins are appealing candidates. Indeed, knockout of SDC1 
leads to reduced Akt phosphorylation in response to shear-stress.(Voyvodic et al., 2014)  
SDC1 is a co-receptor to several integrins, and many of the shear-stress-mediated 
responses, including Akt phosphorylation, have been observed by previous groups are 
downstream of integrin. In our recent work, we demonstrate first that SDC1, itself, is under 
tension, and that components of its extracellular domain are involved in this force 
propagation. Additionally, the inhibition of players involved in cytoskeletal tension, such 
as ROCK, increases SDC1 tension. Decoupling of SDC1 from the αv integrins increases 
SDC1 tension, while inactivation of αv integrins also increases SDC1 tension at the 
substrate level, implying that the αV integrins contribute to SDC1 tension during binding 
of the ECM.  
SDC1 is required for the activation of integrins αVβ3 and αVβ5(Beauvais et al., 
2009) but has also been shown to require integrin αVβ3 to mediate cell spreading(Beauvais 
et al., 2004) and mediate the alignment of ECM fibers,(Yang & Friedl, 2016) suggesting 
an interdependence between these proteins in mechanosensation. Our data are suggestive 
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of a model in which, upon adhering, the cell reaches out with SDC1, binding the ECM. At 
that moment, SDC1 is tense and stretched. The integrins, however, cannot reach the ECM 
due to their size relative to SDC1. SDC1 then may bind to the integrin, causing SDC1 to 
shorten and its tension to decrease. In such a model, mature focal adhesions would spatially 
exclude SDC1. This model is supported by other work that has indicated that syndecans 
are absent in mature focal adhesions.(Roper, Williamson, & Bass, 2012)  
The presence of DMSO in our cytoskeletal disruption and focal adhesion disruption 
experiments pose some challenges for the interpretation of FRET following the drug 
treatments. Additionally, our method of quantification may fail to capture local changes in 
FRET distribution in response to the treatments. For this reason, we made some qualitative 
observations of the leading edges of the cells before and after treatment. We observed that 
at baseline levels, a thin, high-tension edge appears to be present in the leading edge, along 
with high-tension filopodia and a distinctive FRET pattern within the leading edge that 
resembled high- and low-tension patches. After treatment with Y27632 and PF-573,228, 
this pattern appears to change, while treatment with the active isoform of Blebbistatin and 
PP2 resulted in no change in this FRET pattern, which may suggest that Rock and FAK 
are involved in SDC1 tension, but myosin ii and the src-family kinases are not.  
The hunt for mechanosensors of shear stress has pointed to several potential 
proteins. Integrin αVβ3 is known to undergo activation, primarily at the endothelial-
substrate interface, in response to shear stress.(Chen et al., 2015; Tzima, del Pozo, Shattil, 
Chien, & Schwartz, 2001) Previous work found that knockdown of SDC1 in bovine aortic 
 115 
endothelial cells abrogated endothelial cell elongation in the direction of flow, indicating 
that SDC1 is required for the transmission of flow-mediated force to the 
cytoskeleton.(Ebong, Lopez-Quintero, Rizzo, Spray, & Tarbell, 2014) Loss of SDC1 has 
also been observed to abolish several early signaling events occur in endothelial cells 
within 15 minutes of shear-stress application, including Akt phosphorylation, the 
establishment of a spatial phosphorylation gradient in paxillin  and RhoA 
activation.(Voyvodic et al., 2014)   In this study, tension on the complete Sdc1TS was 
responsive to the application of shear stress within 15 minutes of the initiation of flow. The 
lack of tension response in the TSΔEcto sensor in response to shear stress suggests that 
SDC1s interaction with αv integrins is necessary for its ability to mechanosense, consistent 
with the activation of integrin αVβ3 in response to shear stress.  
Our shear stress experiments suggest that the GAG chains of SDC1 are important 
for upstream surface-level tension formation in SDC1 in response to flow. Our observation 
that compression occurs on the SDC1-TS and TSΔCyto but not TSΔEcto and TSΔGAG 
suggest that GAGs are essential for developing compression at the downstream substrate 
level. As a cell experiences shear stress, it may be that the cell is being pulled by shear 
stress on the upstream side, leading to the cell resisting fluidic shear on the downstream 




Chapter 6. Conclusions 
 
SDC1’s list of functions is ever expanding, and our work provides new evidence 
for SDC1 in vascular mechanosensing. Building on previous work from our group, we 
found that SDC1 is involved in sensing nanotopography in engineered materials. SDC1 
Nanotopography, itself, can alter signaling through the TGF-β and Hippo pathways 
through the regulation of cytoskeletal tension. In Chapter 4, we developed and validated a 
SDC1 tension sensor, which enabled the visualization of changes in tension on SDC1 
during mechanosensation. We found that SDC1 tension increases with substrate stiffness 
and can be altered with nanopatterning. One unexpected finding was that loss of the SDC1 
cytoplasmic domain increased SDC1 tension. In Chapter 5, our work indicated that SDC1 
tension is influenced by its binding to αV integrins. Additionally, we demonstrated that 
during shear-stress, endothelial cells exhibit a spatial gradient of SDC1 tension that 
requires the SDC1 ectodomain. We observed tension on SDC1 on the upstream region of 
the cell and compression on SDC1 on the downstream region.  
Future work is needed to solidify SDC1’s mechanosensing story. One obvious 
future direction would involve incorporating FLIM to our FRET evaluation approach. 
Utilizing light sheet microscopy would improve temporal resolution and enable the 
evaluation of FRET in earlier phases of SDC1 tension propagation. Co-
immunoprecipitation of proteins bound to SDC1 during SDC1 mechanosensing of 
compliance substrates and shear-stress would further elucidate SDC1 mechanosensing 
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mechanisms. Time-lapse FRET imaging of migrating cells expressing the tension sensors 
would enable the examination of SDC1 tension in the leading versus the lagging end.  
Another topic that could be explored is the impact of ECM component on SDC1 tension 
and strength of binding. In this work, we only utilized type I collagen, but SDC1 is known 
to bind other ECM proteins, such as fibronectin, tropoelastin, laminin, vitronectin, among 
others.(Stepp et al., 2002)  
We applied shear-stress to non-confluent endothelial cells, which yielded 
interesting insight into the spatial distribution of SDC1 tension across endothelial cells. 
Ideally, these experiments would have also been performed on a confluent monolayer of 
endothelial cells to better mimic the intimal layer of arteries in vitro.  However, our 
attempts to culture a monolayer with our TS-expressing cell lines were unsuccessful. Even 
cultured at high confluency, our cells overlapped. Previous work from other groups has 
shown that lower or higher than normal SDC1 expression in endothelial cells can induce 
phenotype and morphological changes leading to similar overlapping.  The creation of cell 
lines that express SDC1—both SDC1TS and wild-type SDC1—at “normal” levels could 
help to address this problem. 
 In the future, expression of the SDC1TS in vascular smooth muscle cells would 
enable the examination of SDC1 tension in the context of smooth muscle cell function. 
Additionally, the combination of SDC1TS expression and knockdown of SDC1 in 
endothelial cells would enable future researchers to examine tension on SDC1TS in the 
absence of potential effects of wild-type SDC1 on the glycocalyx.  
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 A broad goal of understanding the role of SDC1 in vascular mechanosensing is 
utilizing those insights to engineer improved vascular grafts. Endothelial or smooth muscle 
cells expressing the SDC1TS could be seeded into vascular grafts to study SDC1 tension 
during colonization of the graft and later, during various flow conditions. Additionally, as 
SDC1 is involved in leukocyte adhesion to endothelial cells, the SDC1TS could be used to 
understand SDC1 tension during leukocyte attachment and rolling.  
Clearly, there are many exciting potential uses for the SDC1TS toward the aim of 
increasing our understanding of its complex role in mechanosensation.  
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Appendix A. Sequence of Syndecan-1 Tension Sensor 
Human SDC1 with TSMod tension sensing construct indicated in bold font.(Grashoff et 
al., 2010a) 
 
        1 GGCCGGGAGA CCTGGCGGAG CTGGGGGTGG GGGGCCAGTT TTTGCAACGG CTAAGGAAGG 
       61 GCCTGTGGGT TTATTATAAG GCGGAGCTCG GCGGGAGAGG TGCGGGCCGA ATCCGAGCCG 
      121 AGCGGAGAGG AATCCGGCAG TAGAGAGCGG ACTCCAGCCG GCGGACCCTG CAGCCCTCGC 
      181 CTGGGACAGC GGCGCGCTGG GCAGGCGCCC AAGAGAGCAT CGAGCAGCGG AACCCGCGAA 
      241 GCCGGCCCGC AGCCGCGACC CGCGCAGCCT GCCGCTCTCC CGCCGCCGGT CCGGGCAGCA 
      301 TGAGGCGCGC GGCGCTCTGG CTCTGGCTGT GCGCGCTGGC GCTGAGCCTG CAGCCGGCCC 
      361 TGCCGCAAAT TGTGGCTACT AATTTGCCCC CTGAAGATCA AGATGGCTCT GGGGATGACT 
      421 CTGACAACTT CTCCGGCTCA GGTGCAGGTG CTTTGCAAGA TATCACCTTG TCACAGCAGA 
      481 CCCCCTCCAC TTGGAAGGAC ACGCAGCTCC TGACGGCTAT TCCCACGTCT CCAGAACCCA 
      541 CCGGCCTGGA GGCTACAGCT GCCTCCACCT CCACCCTGCC GGCTGGAGAG GGGCCCAAGG 
      601 AGGGAGAGGC TGTAGTCCTG CCAGAAGTGG AGCCTGGCCT CACCGCCCGG GAGCAGGAGG 
      661 CCACCCCCCG ACCCAGGGAG ACCACACAGC TCCCGACCAC TCATCAGGCC TCAACGACCA 
      721 CAGCCACCAC GGCCCAGGAG CCCGCCACCT CCCACCCCCA CAGGGACATG CAGCCTGGCC 
      781 ACCATGAGAC CTCAACCCCT GCAGGACCCA GCCAAGCTGA CCTTCACACT CCCCACACAG 
      841 AGGATGGAGG TCCTTCTGCC ACCGAGAGGG CTGCTGAGGA TGGAGCCTCC AGTCAGCTCC 
      901 CAGCAGCAGA GGGCTCTGGG GAGCAGGACT TCACCTTTGA AACCTCGGGG GAGAATACGG 
      961 CTGTAATGGT GAGCAAGGGC GAGGAGACCA CAATGGGCGT AATCAAGCCC GACATGAAGA 
     1021 TCAAGCTGAA GATGGAGGGC AACGTGAATG GCCACGCCTT CGTGATCGAG GGCGAGGGCG 
     1081 AGGGCAAGCC CTACGACGGC ACCAACACCA TCAACCTGGA GGTGAAGGAG GGAGCCCCCC 
     1141 TGCCCTTCTC CTACGACATT CTGACCACCG CGTTCGCCTA CGGCAACAGG GCCTTCACCA 
     1201 AGTACCCCGA CGACATCCCC AACTACTTCA AGCAGTCCTT CCCCGAGGGC TACTCTTGGG 
     1261 AGCGCACCAT GACCTTCGAG GACAAGGGCA TCGTGAAGGT GAAGTCCGAC ATCTCCATGG 
     1321 AGGAGGACTC CTTCATCTAC GAGATACACC TCAAGGGCGA GAACTTCCCC CCCAACGGCC 
     1381 CCGTGATGCA GAAGAAGACC ACCGGCTGGG ACGCCTCCAC CGAGAGGATG TACGTGCGCG 
     1441 ACGGCGTGCT GAAGGGCGAC GTCAAGCACA AGCTGCTGCT GGAGGGCGGC GGCCACCACC 
     1501 GCGTTGACTT CAAGACCATC TACAGGGCCA AGAAGGCGGT GAAGCTGCCC GACTATCACT 
     1561 TTGTGGACCA CCGCATCGAG ATCCTGAACC ACGACAAGGA CTACAACAAG GTGACCGTTT 
     1621 ACGAGAGCGC CGTGGCCCGC AACTCCACCG ACGGCATGGA CGAGCTGTAC AAGGGGCCAG 
     1681 GTGGTGCAGG GCCAGGTGGT GCAGGGCCAG GTGGTGCAGG GCCAGGTGGT GCAGGGCCCG 
     1741 GTGGTGCAGG TCCAGGTGGT GCAGGTCCAG GTGGTGCAGG TCCAGGTGGT GCTATGGTGA 
     1801 GCAAGGGCGA GGAGCTGTTC ACCGGGGTGG TGCCCATCCT GGTCGAGCTG GACGGCGACG 
     1861 TAAACGGCCA CAAGTTCAGC GTGTCCGGCG AGGGCGAGGG CGATGCCACC TACGGCAAGC 
     1921 TGACCCTGAA GCTGATCTGC ACCACCGGCA AGCTGCCCGT GCCCTGGCCC ACCCTCGTGA 
     1981 CCACCCTGGG CTACGGCCTG CAGTGCTTCG CCCGCTACCC CGACCACATG AAGCAGCACG 
     2041 ACTTCTTCAA GTCCGCCATG CCCGAAGGCT ACGTCCAGGA GCGCACCATC TTCTTCAAGG 
     2101 ACGACGGCAA CTACAAGACC CGCGCCGAGG TGAAGTTCGA GGGCGACACC CTGGTGAACC 
     2161 GCATCGAGCT GAAGGGCATC GACTTCAAGG AGGACGGCAA CATCCTGGGG CACAAGCTGG 
     2221 AGTACAACTA CAACAGCCAC AACGTCTATA TCACCGCCGA CAAGCAGAAG AACGGCATCA 
     2281 AGGCCAACTT CAAGATCCGC CACAACATCG AGGACGGCGG CGTGCAGCTC GCCGACCACT 
     2341 ACCAGCAGAA CACCCCCATC GGCGACGGCC CCGTGCTGCT GCCCGACAAC CACTACCTGA 
     2401 GCTACCAGTC CAAGCTGAGC AAAGACCCCA ACGAGAAGCG CGATCACATG GTCCTGCTGG 
     2461 AGTTCGTGAC CGCCGCCGGG ATCACTCTCG GCATGGACGA GCTGTACAAG TAAGTGGCCG 
     2521 TGGAGCCTGA CCGCCGGAAC CAGTCCCCAG TGGATCAGGG GGCCACGGGG GCCTCACAGG 
     2581 GCCTCCTGGA CAGGAAAGAG GTGCTGGGAG GGGTCATTGC CGGAGGCCTC GTGGGGCTCA 
     2641 TCTTTGCTGT GTGCCTGGTG GGTTTCATGC TGTACCGCAT GAAGAAGAAG GACGAAGGCA 
     2701 GCTACTCCTT GGAGGAGCCG AAACAAGCCA ACGGCGGGGC CTACCAGAAG CCCACCAAAC 
     2761 AGGAGGAATT CTATGCCTGA CGCGGGAGCC ATGCGCCCCC TCCGCCCTGC CACTCACTAG 
     2821 GCCCCCACTT GCCTCTTCCT TGAAGAACTG CAGGCCCTGG CCTCCCCTGC CACCAGGCCA 
     2881 CCTCCCCAGC ATTCCAGCCC CTCTGGTCGC TCCTGCCCAC GGAGTCGTGG GGTGTGCTGG 
     2941 GAGCTCCACT CTGCTTCTCT GACTTCTGCC TGGAGACTTA GGGCACCAGG GGTTTCTCGC 
     3001 ATAGGACCTT TCCACCACAG CCAGCACCTG GCATCGCACC ATTCTGACTC GGTTTCTCCA 
     3061 AACTGAAGCA GCCTCTCCCC AGGTCCAGCT CTGGAGGGGA GGGGGATCCG ACTGCTTTGG 
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     3121 ACCTAAATGG CCTCATGTGG CTGGAAGATC CTGCGGGTGG GGCTTGGGGC TCACACACCT 
     3181 GTAGCACTTA CTGGTAGGAC CAAGCATCTT GGGGGGGTGG CCGCTGAGTG GCAGGGGACA 
     3241 GGAGTCCACT TTGTTTCGTG GGGAGGTCTA ATCTAGATAT CGACTTGTTT TTGCACATGT 
     3301 TTCCTCTAGT TCTTTGTTCA TAGCCCAGTA GACCTTGTTA CTTCTGAGGT AAGTTAAGTA 
     3361 AGTTGATTCG GTATCCCCCC ATCTTGCTTC CCTAATCTAT GGTCGGGAGA CAGCATCAGG 
     3421 GTTAAGAAGA CTTTTTTTTT TTTTTTTTAA ACTAGGAGAA CCAAATCTGG AAGCCAAAAT 
     3481 GTAGGCTTAG TTTGTGTGTT GTCTCTTGAG TTTGTCGCTC ATGTGTGCAA CAGGGTATGG 
     3541 ACTATCTGTC TGGTGGCCCC GTTTCTGGTG GTCTGTTGGC AGGCTGGCCA GTCCAGGCTG 
     3601 CCGTGGGGCC GCCGCCTCTT TCAAGCAGTC GTGCCTGTGT CCATGCGCTC AGGGCCATGC 
     3661 TGAGGCCTGG GCCGCTGCCA CGTTGGAGAA GCCCGTGTGA GAAGTGAATG CTGGGACTCA 
     3721 GCCTTCAGAC AGAGAGGACT GTAGGGAGGG CGGCAGGGGC CTGGAGATCC TCCTGCAGAC 
     3781 CACGCCCGTC CTGCCTGTGG CGCCGTCTCC AGGGGCTGCT TCCTCCTGGA AATTGACGAG 
     3841 GGGTGTCTTG GGCAGAGCTG GCTCTGAGCG CCTCCATCCA AGGCCAGGTT CTCCGTTAGC 
     3901 TCCTGTGGCC CCACCCTGGG CCCTGGGCTG GAATCAGGAA TATTTTCCAA AGAGTGATAG 
     3961 TCTTTTGCTT TTGGCAAAAC TCTACTTAAT CCAATGGGTT TTTCCCTGTA CAGTAGATTT 
     4021 TCCAAATGTA ATAAACTTTA ATATAAAGTA GTCCTGTGAA TGCCACTGCC TTCGCTTCTT 
     4081 GCCTCTGTGC TGTGTGTGAC GTGACCGGAC TTTTCTGCAA ACACCAACAT GTTGGGAAAC 
     4141 TTGGCTCGAA TCTCTGTGCC TTCGTCTTTC CCATGGGGAG GGATTCTGGT TCCAGGGTCC 
     4201 CTCTGTGTAT TTGCTTTTTT GTTTTGGCTG AAATTCTCCT GGAGGTCGGT AGGTTCAGCC 
     4261 AAGGTTTTAT AAGGCTGATG TCAATTTCTG TGTTGCCAAG CTCCAAGCCC CATCTTCTAA 
     4321 ATGGCAAAGG AAGGTGGATG GCCCCAGCAC AGCTTGACCT GAGGCTGTGG TCACAGCGGA 
     4381 GGTGTGGAGC CGAGGCCTAC CCCGCAGACA CCTTGGACAT CCTCCTCCCA CCCGGCTGCA 
     4441 GAGGCCAGAG GCCCCCAGCC CAGGGCTCCT GCACTTACTT GCTTATTTGA CAACGTTTCA 
     4501 GCGACTCCGT TGGCCACTCC GAGAGGTGGG CCAGTCTGTG GATCAGAGAT GCACCACCAA 
     4561 GCCAAGGGAA CCTGTGTCCG GTATTCGATA CTGCGACTTT CTGCCTGGAG TGTATGACTG 
     4621 CACATGACTC GGGGGTGGGG AAAGGGGTCG GCTGACCATG CTCATCTGCT GGTCCGTGGG 
     4681 ACGGTGCCCA AGCCAGAGGC TGGGTTCATT TGTGTAACGA CAATAAACGG TACTTGTCAT 
     4741 TTCGGGCAAA AAAAAAAAAA AAAAA 
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 1 AAAGTGGTTG ATCGCGTGCA TGCGACGTCA TAGCTCTCTC CCAATTCTCG ACCTCGAGAC 
       61 AAATGGCAGT ATTCATCCAC AATTTTAAAA GAAAAGGGGG GATTGGGGGG TACAGTGCAG 
      121 GGGAAAGAAT AGTAGACATA ATAGCAACAG ACATACAAAC TAAAGAATTA CAAAAACAAA 
      181 TTACAAAAAT TCAAAATTTT CGGGTTTATT ACAGGGACAG CAGAGATCCA GTTTGGCCGC 
      241 GGCTCGAGGG GGTTGGGGTT GCGCCTTTTC CAAGGCAGCC CTGGGTTTGC GCAGGGACGC 
      301 GGCTGCTCTG GGCGTGGTTC CGGGAAACGC AGCGGCGCCG ACCCTGGGTC TCGCACATTC 
      361 TTCACGTCCG TTCGCAGCGT CACCCGGATC TTCGCCGCTA CCCTTGTGGG CCCCCCGGCG 
      421 ACGCTTCCTG CTCCGCCCCT AAGTCGGGAA GGTTCCTTGC GGTTCGCGGC GTGCCGGACG 
      481 TGACAAACGG AAGCCGCACG TCTCACTAGT ACCCTCGCAG ACGGACAGCG CCAGGGAGCA 
      541 ATGGCAGCGC GCCGACCGCG ATGGGCTGTG GCCAATAGCG GCTGCTCAGC AGGGCGCGCC 
      601 GAGAGCAGCG GCCGGGAAGG GGCGGTGCGG GAGGCGGGGT GTGGGGCGGT AGTGTGGGCC 
      661 CTGTTCCTGC CCGCGCGGTG TTCCGCATTC TGCAAGCCTC CGGAGCGCAC GTCGGCAGTC 
      721 GGCTCCCTCG TTGACCGAAT CACCGACCTC TCTCCCCAGG GGGATCCACC GGAGCTTACC 
      781 ATGACCGAGT ACAAGCCCAC GGTGCGCCTC GCCACCCGCG ACGACGTCCC CAGGGCGGTA 
      841 CGCACCCTCG CCGCCGCGTT CGCCGACTAC CCCGCCACGC GCCACACCGT CGATCCGGAC 
      901 CGCCACATCG AGCGGGTCAC CGAGCTGCAA GAACTCTTCC TCACGCGCGT CGGGCTCGAC 
      961 ATCGGCAAGG TGTGGGTCGC GGACGACGGC GCCGCGGTGG CGGTCTGGAC CACGCCGGAG 
     1021 AGCGTCGAAG CGGGGGCGGT GTTCGCCGAG ATCGGCCCGC GCATGGCCGA GTTGAGCGGT 
     1081 TCCCGGCTGG CCGCGCAGCA ACAGATGGAA GGCCTCCTGG CGCCGCACCG GCCCAAGGAG 
     1141 CCCGCGTGGT TCCTGGCCAC CGTCGGCGTC TCGCCCGACC ACCAGGGCAA GGGTCTGGGC 
     1201 AGCGCCGTCG TGCTCCCCGG AGTGGAGGCG GCCGAGCGCG CCGGGGTGCC CGCCTTCCTG 
     1261 GAGACCTCCG CGCCCCGCAA CCTCCCCTTC TACGAGCGGC TCGGCTTCAC CGTCACCGCC 
     1321 GACGTCGAGG TGCCCGAAGG ACCGCGCACC TGGTGCATGA CCCGCAAGCC CGGTGCCTGA 
     1381 CGCCCGCCCC ACGACCCGCA GCGCCCGACC GAAAGGAGCG CACGACCCCA TGCATCGGTA 
     1441 CCTTTAAGAC CAATGACTTA CAAGGCAGCT GTAGATCTTA GCCACTTTTT AAAAGAAAAG 
     1501 GGGGGACTGG AAGGGCTAAT TCACTCCCAA CGAAGACAAG ATCTGCTTTT TGCTTGTACT 
     1561 GGGTCTCTCT GGTTAGACCA GATCTGAGCC TGGGAGCTCT CTGGCTAACT AGGGAACCCA 
     1621 CTGCTTAAGC CTCAATAAAG CTTGCCTTGA GTGCTTCAAG TAGTGTGTGC CCGTCTGTTG 
     1681 TGTGACTCTG GTAACTAGAG ATCCCTCAGA CCCTTTTAGT CAGTGTGGAA AATCTCTAGC 
     1741 AGTAGTAGTT CATGTCATCT TATTATTCAG TATTTATAAC TTGCAAAGAA ATGAATATCA 
     1801 GAGAGTGAGA GGAACTTGTT TATTGCAGCT TATAATGGTT ACAAATAAAG CAATAGCATC 
     1861 ACAAATTTCA CAAATAAAGC ATTTTTTTCA CTGCATTCTA GTTGTGGTTT GTCCAAACTC 
     1921 ATCAATGTAT CTTATCATGT CTGGCTCTAG CTATCCCGCC CCTAACTCCG CCCATCCCGC 
     1981 CCCTAACTCC GCCCAGTTCC GCCCATTCTC CGCCCCATGG CTGACTAATT TTTTTTATTT 
     2041 ATGCAGAGGC CGAGGCCGCC TCGGCCTCTG AGCTATTCCA GAAGTAGTGA GGAGGCTTTT 
     2101 TTGGAGGCCT AGGGACGTAC CCAATTCGCC CTATAGTGAG TCGTATTACG CGCGCTCACT 
     2161 GGCCGTCGTT TTACAACGTC GTGACTGGGA AAACCCTGGC GTTACCCAAC TTAATCGCCT 
     2221 TGCAGCACAT CCCCCTTTCG CCAGCTGGCG TAATAGCGAA GAGGCCCGCA CCGATCGCCC 
     2281 TTCCCAACAG TTGCGCAGCC TGAATGGCGA ATGGGACGCG CCCTGTAGCG GCGCATTAAG 
     2341 CGCGGCGGGT GTGGTGGTTA CGCGCAGCGT GACCGCTACA CTTGCCAGCG CCCTAGCGCC 
     2401 CGCTCCTTTC GCTTTCTTCC CTTCCTTTCT CGCCACGTTC GCCGGCTTTC CCCGTCAAGC 
     2461 TCTAAATCGG GGGCTCCCTT TAGGGTTCCG ATTTAGTGCT TTACGGCACC TCGACCCCAA 
     2521 AAAACTTGAT TAGGGTGATG GTTCACGTAG TGGGCCATCG CCCTGATAGA CGGTTTTTCG 
     2581 CCCTTTGACG TTGGAGTCCA CGTTCTTTAA TAGTGGACTC TTGTTCCAAA CTGGAACAAC 
     2641 ACTCAACCCT ATCTCGGTCT ATTCTTTTGA TTTATAAGGG ATTTTGCCGA TTTCGGCCTA 
     2701 TTGGTTAAAA AATGAGCTGA TTTAACAAAA ATTTAACGCG AATTTTAACA AAATATTAAC 
     2761 GCTTACAATT TAGGTGGCAC TTTTCGGGGA AATGTGCGCG GAACCCCTAT TTGTTTATTT 
     2821 TTCTAAATAC ATTCAAATAT GTATCCGCTC ATGAGACAAT AACCCTGATA AATGCTTCAA 
     2881 TAATATTGAA AAAGGAAGAG TATGAGTATT CAACATTTCC GTGTCGCCCT TATTCCCTTT 
     2941 TTTGCGGCAT TTTGCCTTCC TGTTTTTGCT CACCCAGAAA CGCTGGTGAA AGTAAAAGAT 
     3001 GCTGAAGATC AGTTGGGTGC ACGAGTGGGT TACATCGAAC TGGATCTCAA CAGCGGTAAG 
     3061 ATCCTTGAGA GTTTTCGCCC CGAAGAACGT TTTCCAATGA TGAGCACTTT TAAAGTTCTG 
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     3121 CTATGTGGCG CGGTATTATC CCGTATTGAC GCCGGGCAAG AGCAACTCGG TCGCCGCATA 
     3181 CACTATTCTC AGAATGACTT GGTTGAGTAC TCACCAGTCA CAGAAAAGCA TCTTACGGAT 
     3241 GGCATGACAG TAAGAGAATT ATGCAGTGCT GCCATAACCA TGAGTGATAA CACTGCGGCC 
     3301 AACTTACTTC TGACAACGAT CGGAGGACCG AAGGAGCTAA CCGCTTTTTT GCACAACATG 
     3361 GGGGATCATG TAACTCGCCT TGATCGTTGG GAACCGGAGC TGAATGAAGC CATACCAAAC 
     3421 GACGAGCGTG ACACCACGAT GCCTGTAGCA ATGGCAACAA CGTTGCGCAA ACTATTAACT 
     3481 GGCGAACTAC TTACTCTAGC TTCCCGGCAA CAATTAATAG ACTGGATGGA GGCGGATAAA 
     3541 GTTGCAGGAC CACTTCTGCG CTCGGCCCTT CCGGCTGGCT GGTTTATTGC TGATAAATCT 
     3601 GGAGCCGGTG AGCGTGGGTC TCGCGGTATC ATTGCAGCAC TGGGGCCAGA TGGTAAGCCC 
     3661 TCCCGTATCG TAGTTATCTA CACGACGGGG AGTCAGGCAA CTATGGATGA ACGAAATAGA 
     3721 CAGATCGCTG AGATAGGTGC CTCACTGATT AAGCATTGGT AACTGTCAGA CCAAGTTTAC 
     3781 TCATATATAC TTTAGATTGA TTTAAAACTT CATTTTTAAT TTAAAAGGAT CTAGGTGAAG 
     3841 ATCCTTTTTG ATAATCTCAT GACCAAAATC CCTTAACGTG AGTTTTCGTT CCACTGAGCG 
     3901 TCAGACCCCG TAGAAAAGAT CAAAGGATCT TCTTGAGATC CTTTTTTTCT GCGCGTAATC 
     3961 TGCTGCTTGC AAACAAAAAA ACCACCGCTA CCAGCGGTGG TTTGTTTGCC GGATCAAGAG 
     4021 CTACCAACTC TTTTTCCGAA GGTAACTGGC TTCAGCAGAG CGCAGATACC AAATACTGTT 
     4081 CTTCTAGTGT AGCCGTAGTT AGGCCACCAC TTCAAGAACT CTGTAGCACC GCCTACATAC 
     4141 CTCGCTCTGC TAATCCTGTT ACCAGTGGCT GCTGCCAGTG GCGATAAGTC GTGTCTTACC 
     4201 GGGTTGGACT CAAGACGATA GTTACCGGAT AAGGCGCAGC GGTCGGGCTG AACGGGGGGT 
     4261 TCGTGCACAC AGCCCAGCTT GGAGCGAACG ACCTACACCG AACTGAGATA CCTACAGCGT 
     4321 GAGCTATGAG AAAGCGCCAC GCTTCCCGAA GGGAGAAAGG CGGACAGGTA TCCGGTAAGC 
     4381 GGCAGGGTCG GAACAGGAGA GCGCACGAGG GAGCTTCCAG GGGGAAACGC CTGGTATCTT 
     4441 TATAGTCCTG TCGGGTTTCG CCACCTCTGA CTTGAGCGTC GATTTTTGTG ATGCTCGTCA 
     4501 GGGGGGCGGA GCCTATGGAA AAACGCCAGC AACGCGGCCT TTTTACGGTT CCTGGCCTTT 
     4561 TGCTGGCCTT TTGCTCACAT GTTCTTTCCT GCGTTATCCC CTGATTCTGT GGATAACCGT 
     4621 ATTACCGCCT TTGAGTGAGC TGATACCGCT CGCCGCAGCC GAACGACCGA GCGCAGCGAG 
     4681 TCAGTGAGCG AGGAAGCGGA AGAGCGCCCT TTGAGTGAGC TGATACCGCT CGCCGCAGCC 
     4741 GAACGACCGA GCGCAGCGAG TCAGTGAGCG AGGAAGCGGA AGAGCGCCCA ATACGCAAAC 
     4801 CGCCTCTCCC CGCGCGTTGG CCGATTCATT AATGCAGCTG GCACGACAGG TTTCCCGACT 
     4861 GGAAAGCGGG CAGTGAGCGC AACGCAAAAT GTGAGTTAGC TCACTCATTA GGCACCCCAG 
     4921 GCTTTACACT TTATGCTTCC GGCTCGTATG TTGTGTGGAA TTGTGAGCGG ATAACAATTT 
     4981 CACACAGGAA ACAGCTATGA CCATGATTAC GCCAAGCGCG CAATTAACCC TCACTAAAGG 
     5041 GAACAAAAGC TGGAGCTGCA AGCTTAATGT AGTCTTATGC AATACTCTTG TAGTCTTGCA 
     5101 ACATGGTAAC GATGAGTTAG CAACATGCCT TACAAGGAGA GAAAAAGCAC CGTGCATGCC 
     5161 GATTGGTGGA AGTAAGGTGG TACGATCGTG CCTTATTAGG AAGGCAACAG ACGGGTCTGA 
     5221 CATGGATTGG ACGAACCACT GAATTGCCGC ATTGCAGAGA TATTGTATTT AAGTGCCTAG 
     5281 CTCGATACAT AAACGGGTCT CTCTGGTTAG ACCAGATCTG AGCCTGGGAG CTCTCTGGCT 
     5341 AACTAGGGAA CCCACTGCTT AAGCCTCAAT AAAGCTTGCC TTGAGTGCTT CAAGTAGTGT 
     5401 GTGCCCGTCT GTTGTGTGAC TCTGGTAACT AGAGATCCCT CAGACCCTTT TAGTCAGTGT 
     5461 GGAAAATCTC TAGCAGTGGC GCCCGAACAG GGACTTGAAA GCGAAAGGGA AACCAGAGGA 
     5521 GCTCTCTCGA CGCAGGACTC GGCTTGCTGA AGCGCGCACG GCAAGAGGCG AGGGGCGGCG 
     5581 ACTGGTGAGT ACGCCAAAAA TTTTGACTAG CGGAGGCTAG AAGGAGAGAG ATGGGTGCGA 
     5641 GAGCGTCAGT ATTAAGCGGG GGAGAATTAG ATCGCGATGG GAAAAAATTC GGTTAAGGCC 
     5701 AGGGGGAAAG AAAAAATATA AATTAAAACA TATAGTATGG GCAAGCAGGG AGCTAGAACG 
     5761 ATTCGCAGTT AATCCTGGCC TGTTAGAAAC ATCAGAAGGC TGTAGACAAA TACTGGGACA 
     5821 GCTACAACCA TCCCTTCAGA CAGGATCAGA AGAACTTAGA TCATTATATA ATACAGTAGC 
     5881 AACCCTCTAT TGTGTGCATC AAAGGATAGA GATAAAAGAC ACCAAGGAAG CTTTAGACAA 
     5941 GATAGAGGAA GAGCAAAACA AAAGTAAGAC CACCGCACAG CAAGCGGCCG CTGATCTTCA 
     6001 GACCTGGAGG AGGAGATATG AGGGACAATT GGAGAAGTGA ATTATATAAA TATAAAGTAG 
     6061 TAAAAATTGA ACCATTAGGA GTAGCACCCA CCAAGGCAAA GAGAAGAGTG GTGCAGAGAG 
     6121 AAAAAAGAGC AGTGGGAATA GGAGCTTTGT TCCTTGGGTT CTTGGGAGCA GCAGGAAGCA 
     6181 CTATGGGCGC AGCGTCAATG ACGCTGACGG TACAGGCCAG ACAATTATTG TCTGGTATAG 
     6241 TGCAGCAGCA GAACAATTTG CTGAGGGCTA TTGAGGCGCA ACAGCATCTG TTGCAACTCA 
     6301 CAGTCTGGGG CATCAAGCAG CTCCAGGCAA GAATCCTGGC TGTGGAAAGA TACCTAAAGG 
     6361 ATCAACAGCT CCTGGGGATT TGGGGTTGCT CTGGAAAACT CATTTGCACC ACTGCTGTGC 
     6421 CTTGGAATGC TAGTTGGAGT AATAAATCTC TGGAACAGAT TTGGAATCAC ACGACCTGGA 
     6481 TGGAGTGGGA CAGAGAAATT AACAATTACA CAAGCTTAAT ACACTCCTTA ATTGAAGAAT 
     6541 CGCAAAACCA GCAAGAAAAG AATGAACAAG AATTATTGGA ATTAGATAAA TGGGCAAGTT 
     6601 TGTGGAATTG GTTTAACATA ACAAATTGGC TGTGGTATAT AAAATTATTC ATAATGATAG 
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     6661 TAGGAGGCTT GGTAGGTTTA AGAATAGTTT TTGCTGTACT TTCTATAGTG AATAGAGTTA 
     6721 GGCAGGGATA TTCACCATTA TCGTTTCAGA CCCACCTCCC AACCCCGAGG GGACCCGACA 
     6781 GGCCCGAAGG AATAGAAGAA GAAGGTGGAG AGAGAGACAG AGACAGATCC ATTCGATTAG 
     6841 TGAACGGATC TCGACGGTAT CGATCACGAG ACTAGCCTCG AGCGGCCGCC CCCTTCACCG 
     6901 AGGGCCTATT TCCCATGATT CCTTCATATT TGCATATACG ATACAAGGCT GTTAGAGAGA 
     6961 TAATTGGAAT TAATTTGACT GTAAACACAA AGATATTAGT ACAAAATACG TGACGTAGAA 
     7021 AGTAATAATT TCTTGGGTAG TTTGCAGTTT TAAAATTATG TTTTAAAATG GACTATCATA 
     7081 TGCTTACCGT AACTTGAAAG TATTTCGATT TCTTGGCTTT ATATATCTTG TGGAAAGGAC 
     7141 GAAACACCGG TGATCTATAC ATTGAATCAA TATTGGCAAT TAGCCATATT AGTCATTGGT 
     7201 TATATAGCAT AAATCAATAT TGGCTATTGG CCATTGCATA CGTTGTATCT ATATCATAAT 
     7261 ATGTACATTT ATATTGGCTC ATGTCCAATA TGACCGCCAT GTTGACATTG ATTATTGACT 
     7321 AGTTATTAAT AGTAATCAAT TACGGGGTCA TTAGTTCATA GCCCATATAT GGAGTTCCGC 
     7381 GTTACATAAC TTACGGTAAA TGGCCCGCCT GGCTGACCGC CCAACGACCC CCGCCCATTG 
     7441 ACGTCAATAA TGACGTATGT TCCCATAGTA ACGCCAATAG GGACTTTCCA TTGACGTCAA 
     7501 TGGGTGGAGT ATTTACGGTA AACTGCCCAC TTGGCAGTAC ATCAAGTGTA TCATATGCCA 
     7561 AGTCCGCCCC CTATTGACGT CAATGACGGT AAATGGCCCG CCTGGCATTA TGCCCAGTAC 
     7621 ATGACCTTAC GGGACTTTCC TACTTGGCAG TACATCTACG TATTAGTCAT CGCTATTACC 
     7681 ATGGTGATGC GGTTTTGGCA GTACATCAAT GGGCGTGGAT AGCGGTTTGA CTCACGGGGA 
     7741 TTTCCAAGTC TCCACCCCAT TGACGTCAAT GGGAGTTTGT TTTGGCACCA AAATCAACGG 
     7801 GACTTTCCAA AATGTCGTAA CAACTCCGCC CCATTGACGC AAATGGGCGG TAGGCGTGTA 
     7861 CGGTGGGAGG TCTATATAAG CAGAGCTCGT TTAGTGAACC GTCAGATCGC CTGGAGACGC 
     7921 CATCCACGCT GTTTTGACCT CCATAGAAGA TTCTAGATTC GAAGAACAAG TTTGTACAAA 
     7981 AAAGCAGGCT CCACCATGAG GCGCGCGGCG CTCTGGCTCT GGCTGTGCGC GCTGGCGCTG 
     8041 AGCCTGCAGC CGGCCCTGCC GCAAATTGTG GCTACTAATT TGCCCCCTGA AGATCAAGAT 
     8101 GGCTCTGGGG ATGACTCTGA CAACTTCTCC GGCTCAGGTG CAGGTGCTTT GCAAGATATC 
     8161 ACCTTGTCAC AGCAGACCCC CTCCACTTGG AAGGACACGC AGCTCCTGAC GGCTATTCCC 
     8221 ACGTCTCCAG AACCCACCGG CCTGGAGGCT ACAGCTGCCT CCACCTCCAC CCTGCCGGCT 
     8281 GGAGAGGGGC CCAAGGAGGG AGAGGCTGTA GTCCTGCCAG AAGTGGAGCC TGGCCTCACC 
     8341 GCCCGGGAGC AGGAGGCCAC CCCCCGACCC AGGGAGACCA CACAGCTCCC GACCACTCAT 
     8401 CAGGCCTCAA CGACCACAGC CACCACGGCC CAGGAGCCCG CCACCTCCCA CCCCCACAGG 
     8461 GACATGCAGC CTGGCCACCA TGAGACCTCA ACCCCTGCAG GACCCAGCCA AGCTGACCTT 
     8521 CACACTCCCC ACACAGAGGA TGGAGGTCCT TCTGCCACCG AGAGGGCTGC TGAGGATGGA 
     8581 GCCTCCAGTC AGCTCCCAGC AGCAGAGGGC TCTGGGGAGC AGGACTTCAC CTTTGAAACC 
     8641 TCGGGGGAGA ATACGGCTGT AATGGTGAGC AAGGGCGAGG AGACCACAAT GGGCGTAATC 
     8701 AAGCCCGACA TGAAGATCAA GCTGAAGATG GAGGGCAACG TGAATGGCCA CGCCTTCGTG 
     8761 ATCGAGGGCG AGGGCGAGGG CAAGCCCTAC GACGGCACCA ACACCATCAA CCTGGAGGTG 
     8821 AAGGAGGGAG CCCCCCTGCC CTTCTCCTAC GACATTCTGA CCACCGCGTT CGCCTACGGC 
     8881 AACAGGGCCT TCACCAAGTA CCCCGACGAC ATCCCCAACT ACTTCAAGCA GTCCTTCCCC 
     8941 GAGGGCTACT CTTGGGAGCG CACCATGACC TTCGAGGACA AGGGCATCGT GAAGGTGAAG 
     9001 TCCGACATCT CCATGGAGGA GGACTCCTTC ATCTACGAGA TACACCTCAA GGGCGAGAAC 
     9061 TTCCCCCCCA ACGGCCCCGT GATGCAGAAG AAGACCACCG GCTGGGACGC CTCCACCGAG 
     9121 AGGATGTACG TGCGCGACGG CGTGCTGAAG GGCGACGTCA AGCACAAGCT GCTGCTGGAG 
     9181 GGCGGCGGCC ACCACCGCGT TGACTTCAAG ACCATCTACA GGGCCAAGAA GGCGGTGAAG 
     9241 CTGCCCGACT ATCACTTTGT GGACCACCGC ATCGAGATCC TGAACCACGA CAAGGACTAC 
     9301 AACAAGGTGA CCGTTTACGA GAGCGCCGTG GCCCGCAACT CCACCGACGG CATGGACGAG 
     9361 CTGTACAAGG GGCCAGGTGG TGCAGGGCCA GGTGGTGCAG GGCCAGGTGG TGCAGGGCCA 
     9421 GGTGGTGCAG GGCCCGGTGG TGCAGGTCCA GGTGGTGCAG GTCCAGGTGG TGCAGGTCCA 
     9481 GGTGGTGCTA TGGTGAGCAA GGGCGAGGAG CTGTTCACCG GGGTGGTGCC CATCCTGGTC 
     9541 GAGCTGGACG GCGACGTAAA CGGCCACAAG TTCAGCGTGT CCGGCGAGGG CGAGGGCGAT 
     9601 GCCACCTACG GCAAGCTGAC CCTGAAGCTG ATCTGCACCA CCGGCAAGCT GCCCGTGCCC 
     9661 TGGCCCACCC TCGTGACCAC CCTGGGCTAC GGCCTGCAGT GCTTCGCCCG CTACCCCGAC 
     9721 CACATGAAGC AGCACGACTT CTTCAAGTCC GCCATGCCCG AAGGCTACGT CCAGGAGCGC 
     9781 ACCATCTTCT TCAAGGACGA CGGCAACTAC AAGACCCGCG CCGAGGTGAA GTTCGAGGGC 
     9841 GACACCCTGG TGAACCGCAT CGAGCTGAAG GGCATCGACT TCAAGGAGGA CGGCAACATC 
     9901 CTGGGGCACA AGCTGGAGTA CAACTACAAC AGCCACAACG TCTATATCAC CGCCGACAAG 
     9961 CAGAAGAACG GCATCAAGGC CAACTTCAAG ATCCGCCACA ACATCGAGGA CGGCGGCGTG 
    10021 CAGCTCGCCG ACCACTACCA GCAGAACACC CCCATCGGCG ACGGCCCCGT GCTGCTGCCC 
    10081 GACAACCACT ACCTGAGCTA CCAGTCCAAG CTGAGCAAAG ACCCCAACGA GAAGCGCGAT 
    10141 CACATGGTCC TGCTGGAGTT CGTGACCGCC GCCGGGATCA CTCTCGGCAT GGACGAGCTG 
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    10201 TACAAGTAAG TGGCCGTGGA GCCTGACCGC CGGAACCAGT CCCCAGTGGA TCAGGGGGCC 
    10261 ACGGGGGCCT CACAGGGCCT CCTGGACAGG AAAGAGGTGC TGGGAGGGGT CATTGCCGTA 
    10321 GGCCTCGTGG GGCTCATCTT TGCTGTGTGC CTGGTGGGTT TCATGCTGTA CCGCATGAAG 
    10381 AAGAAGGACG AAGGCAGCTA CTCCTTGGAG GAGCCGAAAC AAGCCAACGG CGGGGCCTAC 
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